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CHAPTER 1 
 
INTRODUCTION 
 
Chronic pain is a leading cause of suffering, disability, and high health care 
costs. Patients with chronic pain have elevated health care utilization at primary care 
settings, tertiary care settings, and emergency departments. Furthermore, those 
patients with greater pain-related disability use even more health care services (Blyth, 
March, Brnabic, & Cousins, 2004). Becker et al. (1997) found that chronic pain patients 
are five times more likely to use health care services than those without chronic pain. 
One study examined the economic impact of chronic non-cancer pain in the workplace 
and found that each employer lost an average of $2.1 million per year because of 
absences, medical, and pharmacy costs (Pizzi et al., 2005).  
Although many patients with chronic pain report taking a variety of medications, 
traditional medical interventions often provide limited benefit. Consequently, there has 
been growing interest in the development and testing of psychological interventions for 
people with chronic pain (Gatchel et al., 2007). Interventions that teach people to 
manage their pain using cognitive and behavioral techniques have the most empirical 
support (Compas, Haaga, Keefe, Leitenberg, & Williams, 1998). For example, pain 
coping skills training is a comprehensive, empirically-supported program that includes 
progressive muscle relaxation, distraction, applied relaxation, increasing pleasant 
activities, problem-solving, activity-rest cycling, and cognitive restructuring (Keefe, 
Caldwell, Williams, & Gil, 1990). Morley, Eccleston, and Williams (1999) determined that 
compared with wait-list controls, cognitive-behavioral therapy (CBT) led to better 
outcomes on all dimensions measured, with a median effect size of 0.50. There is also 
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evidence that suggests that cognitive-behavioral treatments work for a range of pain 
disorders. One study compared patients with fibromyalgia and chronic low back pain in 
a cognitive behavioral treatment and found that both patient groups reported a 
significant improvement in self-efficacy, pain, distress, disability, and depression 
symptoms (Wells-Federman, Arnstein, & Caudill-Slosberg, 2003).  
Not all of the studies examining cognitive-behavioral techniques have found such 
positive results, however. A review of an array of psychosocial interventions, but 
primarily cognitive behavioral approaches, for patients with arthritis found a much lower 
effect size of 0.18 in favor of psychological interventions (Dixon, Keefe, Scipio, Perri, & 
Abernathy, 2007).  Also, when comparing cognitive-behavioral treatment with a wait list 
control, Basler and Rehfisch (1990) found improvements on pain immediately following 
treatment, yet at 6-month follow-up, effects were no longer significant. Furthermore, it 
appears that only a subset of patients actually improves (Dixon, Keefe, Scipio, Perri, & 
Abernethy, 2007). The Basler and Rehfisch (1990) study found that the only patients 
with improved pain at the 6-month follow-up were those participants who were most 
adherent to the treatment. Upon studying the effects of various CBT and/or exercise 
interventions for patients with fibromyalgia, Turk (2004) concluded that only about one-
third of patients benefit from the treatment. 
Even though cognitive-behavioral treatments are the standard treatment for 
chronic pain, the overall effects are variable and often limited. One possible explanation 
is that there are different types of pain disorders. Chronic pain can be a symptom of a 
specific disease in the peripheral tissues (e.g. rheumatoid arthritis, inflammatory bowel 
disease, multiple sclerosis, cancer), and such patients need to learn to cope with this 
3 
 
 
 
disease, its medical treatment, and their symptoms.  Improvement through 
psychological interventions may be limited, and cure is not likely. There are, however, 
many examples of chronic pain that lack clear, identifiable peripheral causes. Patients 
with these types of chronic pain have been labeled as having functional disorders, 
medically unexplained symptoms, somatoform disorders, somatization, and so on, and 
include diagnoses such as myofascial pain, fibromyalgia (FM), irritable bowel syndrome 
(IBS), chronic low back pain (CLBP), temporomandibular disorder (TMD), migraine 
headache, tension-type headache.  Such patients likely have different treatment needs 
than those whose pain is largely peripheral in origin. Also, there are similarities across 
these diagnoses (Yunus, 2007), and the presence of elevated stressful life events, 
elevated rates of emotional disorders, and impaired emotion regulation appears to 
contribute to the development and/or maintenance of these types of chronic pain 
problems.  
Stressful Life Events 
One potential contributor to the limited efficacy of standard cognitive-behavioral 
pain management techniques may be the presence of unresolved life stressors, such as 
childhood and adult victimization, serious relationship conflict, shame or guilt-ridden 
actions, or tragic losses. For example, childhood abuse has been associated with many 
health consequences in adulthood. Walker and colleagues found that women with a 
history of sexual abuse had more functional disability, more physical symptoms, more 
medical diagnoses, more emergency room visits, and greater health care costs than 
those without a trauma history (Walker et al., 1999; Walker et al., 1999). Hulme (2000) 
described similar consequences in women from a large primary care clinic; those who 
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had childhood sexual abuse reported twice the physical symptoms, more primary care 
visits, greater medical charges, and twice the amount of major lifetime surgeries 
compared with patients without childhood abuse. 
People with a history of childhood sexual abuse are much more likely to report 
chronic pain than people without a sexual abuse history (Finestone et al., 2000). One 
group of researchers distinguished between childhood abuse, adult abuse, and 
repeated abuse, and found that all three types of abuse were associated with chronic 
pain. However, long-term abuse was associated with a greater level of pain than those 
with reports of childhood and adult abuse alone (Green, Flowe-Valencia, Rosenblum, & 
Tait, 2001). Similarly, when researchers compared a sample with childhood abuse to a 
sample with adult domestic violence, both abuse groups reported more pain symptoms 
than a control group, yet there were no differences in reported pain between the two 
abuse groups (Kendall-Tackett, Marshall, & Ness, 2003). With the exception of long-
term abuse, it does not seem that one type of abuse in either childhood or adulthood is 
more predictive of chronic pain than another type of abuse. 
Additionally, these stressful life events often occur at greater rates in patients 
who develop the somatoform pain disorders than those who have pain related to 
disease. For example, patients with FM had a much higher prevalence of childhood and 
adult victimization than patients with rheumatoid arthritis (Walker et al., 1997). Similarly, 
patients with IBS also had elevated rates of early life stressors, including sexual and 
physical abuse, neglect, and loss of primary caregiver in childhood; and rape in 
adulthood. Furthermore these stressful experiences have been linked with the onset 
and exacerbation of IBS symptoms (Jarcho & Mayer, 2007). Comparing IBS patients to 
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patients who have inflammatory bowel disease (a condition with a clear peripheral—
autoimmune--etiology) reveals a significantly greater level of physical and sexual abuse 
in patients with IBS (Ali et al., 2000).  In a study of the progression of acute neck and 
back pain to chronic pain, greater exposure to past traumatic life events and depressed 
mood were predictive of chronicity (Casey, Greenberg, Nicassio, Harpin, & Hubbard, 
2008).  These authors also found that more cumulative traumatic events, negative pain 
beliefs (e.g., that pain may be permanent), and greater depression in a new pain 
episode was related to increased severity of pain and disability.  
The prior studies used clinical samples, and the help-seeking behavior of clinical 
patients may result in overestimates of traumatic events in these patients.  Several 
epidemiological studies, however, have supported the notion that stressful life events 
are associated with chronic pain (Goodwin, Hoven, Murison, & Hotopf, 2003; Linton, 
2002; McBeth, Macfarlane, Benjamin, Morris, & Silman, 1999). As part of the National 
Comorbidity Survey, Sachs-Ericsson, Kendall-Tackett, and Hernandez (2007) examined 
the relationship between childhood abuse and chronic pain in a large community 
sample. The presence of childhood abuse predicted chronic pain, and the relationship 
between the abuse and chronic pain was not mediated by depression. This study 
confirms that the relationship between abuse and chronic pain is not dependent on 
being in treatment and recruited from treatment sites. 
Emotional Disorders 
 Given the elevated stressful life events reported in chronic pain, one should also 
find elevated rates of posttraumatic stress disorder (PTSD); indeed, this is the case.  
Many studies document the comorbidity of chronic pain and PTSD. Patients with 
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fibromyalgia and irritable bowel syndrome have rates of PTSD up to 37% (Amir et al., 
1997; Dobie et al., 2004), and many additional patients demonstrate subclinical 
symptoms of PTSD (Sherman, Turk, & Okifuji, 2000). Interestingly, the rates of chronic 
pain in people with a primary diagnosis of PTSD are even higher.  Out of 129 
consecutive military veterans with PTSD, 80% reported chronic pain (Beckham et al., 
1997); this suggests that psychological trauma can precede, and presumably elicit, 
chronic pain. 
In addition to PTSD, other emotional disorders are also elevated in patients with 
chronic pain, including mood, anxiety, substance abuse, and personality disorders 
(Twillman, 2007; Weisberg & Boatwright, 2007). In a review of epidemiological data, 
Twillman (2007) found that mood disorders (major depression and dysthymia) and 
anxiety disorders (PTSD, generalized anxiety disorder, panic disorder, social phobia) 
were common in patients with chronic pain. In one study, 68% of patients with chronic 
pain met criteria for at least one Axis I disorder, whereas only 8% of the control 
participants met criteria (Conrad et al., 2007). As would be expected with chronic pain, 
somatoform disorders were most commonly diagnosed (60% vs. 0%); yet, mood 
disorders (45% vs. 3%), anxiety disorders (23% vs. 1%), substance disorders (19% vs. 
2%), and personality disorders (41% vs. 7%) were also substantially elevated.  
An examination of the comorbidity between mood, anxiety, alcohol 
abuse/dependence, and chronic neck or back pain in the worldwide mental health 
surveys revealed that all three disorder categories were more common among people 
with pain than those without pain.  Mood and anxiety disorders had a stronger 
association with chronic pain than did alcohol abuse/dependence. Of the anxiety 
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disorders, generalized anxiety disorder and PTSD showed the strongest association 
(Demyttenaere et al., 2007). Using the same sample, Scott and colleagues (2007) found 
that although depression and anxiety were both independently associated with a range 
of physical conditions, comorbid depression and anxiety had the strongest association 
with several physical conditions including chronic headache, back and neck problems, 
and multiple pains. Furthermore, even though the prevalence of mental and physical 
disorders may differ among ethnic groups, the associations between chronic pain and 
emotional disorders were virtually identical across different ethnicities (Scott, McGee, 
Schaaf, & Baxter, 2008). The evidence clearly supports the argument that a variety of 
emotional disorders are elevated in people with chronic pain, compared with healthy 
controls. However, the presence of an emotional disorder alone does not seem like a 
sufficient explanation for chronic pain, especially because the direction of the 
relationship between chronic pain and emotional disorders is unclear, and emotional 
disorders may reflect underlying mechanisms that may be responsible for both the 
emotional disorder and the pain. 
Emotion Regulation 
Elevated levels of stressful life events and emotional disorders are not the only 
contributors to the development of chronic pain. Rather, it appears that stressful life 
events may give rise to impaired emotion regulation, which may then lead to emotional 
disorders. Although definitions and theoretical views of emotion regulation are still 
evolving (Rottenberg & Gross, 2007), emotional regulation appears to include at least 
four processes.  The first, emotional awareness, involves attending to one’s feelings, 
differentiating feelings from physical states, and labeling one’s feelings.  The second 
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process, emotional expression, involves variations in the degree to which emotions are 
suppressed or expressed, including their imaginal, verbal, and behavioral expression.  A 
third process can be labeled emotional management, and refers to being able to temper 
or elicit various emotions as needed for goal attainment.  The fourth emotion regulation 
process, emotional integration, refers to the emotion-facilitated alteration or relearning 
of maladaptive beliefs and cognitions, with a consequent reduction in negative emotion.  
This occurs by learning about one’s feelings, reflecting on an event’s meaning, and 
either adapting the experience into one’s current thinking, or altering one’s beliefs to 
accommodate the experience.  This dissertation will focus on the first two processes of 
emotion regulation: emotional awareness and emotional expression. 
Although there is little direct evidence linking emotion inhibition and increased 
pain, substantial research suggests that when people avoid or inhibit negative emotions, 
memories, and thoughts stemming from stressful experiences, the central and 
autonomic nervous systems can trigger or exacerbate pain. For example, patients with 
fibromyalgia have greater levels of emotion suppression and alexithymia than controls 
(Brosschot & Aarsse, 2001), and more than half of fibromyalgia patients report difficulty 
expressing emotions, which is much greater than patients with rheumatoid arthritis or 
healthy controls (Dailey, Bishop, Russell, & Fletcher, 1990). Furthermore, in response to 
an induced negative mood and an interpersonal stressor, fibromyalgia patients 
responded with greater pain than patients with osteoarthritis—a peripheral disease-
related pain disorder (Davis, Zautra, & Reich, 2000).  
Alexithymia was originally described in people with psychosomatic disorders and 
is an example of the first emotion regulation process; it encompasses difficulty 
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identifying feelings, difficulty describing feelings, externally oriented thinking, and a 
limited imaginal capacity (Nemiah, Freyberger, & Sifneos, 1976; Taylor, Bagby, & 
Parker, 1997). Elevated levels of alexithymia have been found in a wide range of 
medical conditions including chronic pain and emotional disorders such as PTSD. The 
view that alexithymia is a risk factor for medical and psychiatric problems that are 
influenced by disordered affect regulation is growing in empirical support (Taylor et al., 
1997), and recent studies have begun to link alexithymia to pain.  
Lumley, Neely, and Burger (2007) described potential pathways by which 
alexithymia may influence chronic pain. One way is by contributing to symptom 
reporting. People with alexithymia may be more likely to describe emotional arousal in 
somatic terms or to report only the physiological sensations of emotion rather than the 
emotional label. Also, the tendency to notice and be concerned about physical 
sensations—somatosensory amplification—may be increased in alexithymic individuals. 
Many research studies have found that people with alexithymia report more somatic 
symptoms, including pain. One review of 18 samples reported a mean correlation of r = 
.23 between alexithymia and somatic symptoms (De Gucht & Heiser, 2003). 
Furthermore, alexithymia is usually greater in people with chronic pain than controls 
without pain (Ak et al., 2004; Burba et al., 2006; Celikel & Saatcioglu, 2006). For 
example, alexithymia was associated with nonspecific shoulder pain severity (Miranda 
et al., 2005) and fibromyalgia (Sayar et al., 2004). In addition, alexithymia is positively 
associated with pain severity among people with chronic pain. In a large sample of 
Finish workers with temporomandibular disorder, alexithymia was positively correlated 
with head, neck, and tooth pain (Ahlberg et al., 2004). In a prospective study of patients 
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with temporomandibular disorder, Glaros and Lumley (2005) found that not only was 
alexithymia positively related to pain severity during daily activities even after controlling 
for depressed mood, but also that the pain severity was unrelated to tissue damage. 
Alexithymia is also associated with greater affective pain in patients with chronic 
myofascial pain after controlling for catastrophizing and self-efficacy (Lumley, Smith, & 
Longo, 2002). It appears that alexithymia is related to increased symptom severity 
regardless of tissue damage, which may help explain the similar rates of alexithymia in 
different patient groups. 
The second process of emotion regulation that will be studied in this dissertation 
relates to expression and inhibition of emotions. One line of research examines the 
common regulatory processes of emotion suppression and positive reappraisal. Studies 
examining the effect of suppression on emotional experience have found that although 
suppression is effective at decreasing the outward expression of negative emotions, it 
actually increases physiological arousal and exacerbates the experience of emotion, 
compared with not suppressing (Gross & Levinson, 1997; Gross, 1998). These findings 
are consistent with research documenting the paradoxical nature of thought 
suppression, which shows that when participants are instructed to suppress a thought 
there is actually increased thought on that topic (Gold & Wegner, 1995; Wegner 
Schneider, Carter, & White, 1987). In addition to affecting emotional experience, 
suppression also increases physiological responding (Gross, 2001). For example, 
participants instructed to suppress emotions of disgust experienced greater constriction 
of blood vessels. These effects have also been replicated for amusement and sadness 
but do not occur when participants are instructed to express during a neutral stimulus or 
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when instructed to reappraise. Thus, Gross (2001) concludes that the act of inhibiting 
the expression of emotions impacts physiological factors. 
The use of emotional suppression as a regulation strategy has been linked to the 
development and maintenance of psychopathology (Amstadter, 2008; Gross & John, 
1998). For example, in a sample of Vietnam veterans, those with PTSD used more 
suppression of both negative and positive emotions than those without a PTSD 
diagnosis (Roemer, Litz, Orsillo, & Wagner, 2001). More importantly, greater use of 
suppression was related to greater severity of PTSD symptoms. Therefore, using 
suppression as an emotion regulation strategy leads to increased negative emotions 
and decreased positive emotions in people with PTSD. 
A few studies have researched the effects that anger suppression has on pain. 
Some of the studies have demonstrated the negative effects of suppression on 
experimental pain in healthy controls. Quartana, Yoon, and Burns (2007) found that 
participants in an emotion suppression condition experienced greater pain on a cold-
pressor test during anger provocation than the control condition. These researchers 
also found support for a paradoxical process by which suppressing anger actually 
increases cognitive accessibility of anger. Another study by Quartana and Burns (2007) 
concluded that anger suppression may lead to increased pain because participants in 
the anger suppression condition rated the anger specific dimensions of pain higher than 
the control condition. Recently, this research has been replicated in patients with 
chronic low back pain. Patients were harassed during a computer maze task and were 
randomized to either a suppression or no suppression group. Burns and colleagues 
(2008) found that patients in the anger suppression group had significantly more pain 
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and pain behaviors than the non-suppression group at a subsequent time while 
completing a task designed to mimic everyday activities. Furthermore, degree of anger 
and not anxiety or sadness accounted for the differences between the two groups. 
Even though there is not much research examining the direct effects of avoiding 
emotions on chronic pain, there is a line of research demonstrating the detrimental 
effects of experiential avoidance. Experiential avoidance is the attempt to escape or 
avoid private experiences, typically thoughts, feelings, memories (Hayes & Wilson, 
1993). In the coping literature, there are two methods of avoidance coping that have 
been linked to negative outcomes. Avoidant coping and emotion focused coping, which 
consists of many items that measure avoidance, predict poor clinical outcomes in a 
variety of mental health problems (DeGenova, Patton, Jurich, & MacDermid, 1994; 
Leitenberg, Greenwald, & Cado, 1992). Hayes and colleagues argue that experiential 
avoidance can actually account for the development and maintenance of many 
psychological disorders, including substance disorders, obsessive compulsive disorder, 
panic disorder with agoraphobia, and borderline personality disorder as well as the 
negative effects of childhood sexual abuse (Hayes, Wilson, Gifford, Follette, & Strosahl, 
1996). 
The research on experiential avoidance is consistent with the PTSD literature, a 
diagnosis that is highly comorbid with some chronic pain disorders, and that appears to 
result directly from experiential avoidance of affectively charged memories. Avoidance 
of stimuli associated with the trauma, re-experiencing an element of the trauma, and 
increased sympathetic arousal are criteria of the PTSD diagnosis according to the 
Diagnostic and Statistical Manual, IV-TR (American Psychiatric Association, 2000). The 
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paradoxical effects of thought and emotion suppression noted above may help explain 
the relationship among these three criteria of PTSD. The patient avoids aspects of the 
trauma because they are upsetting and, therefore, the patient is actually more likely to 
re-experience thoughts, feelings, or memories leading to more sympathetic nervous 
system arousal. Furthermore, among patients with PTSD, the use of avoidant coping 
was related to PTSD symptoms at a 1-year follow-up after controlling for initial severity 
(Krause, Kaltman, Goodman, & Dutton, 2008). Thus, the research on experiential 
evidence and its similarities with PTSD suggests that emotional avoidance is an 
important target for chronic pain interventions. 
Addressing Unresolved Stress and Emotions 
Even though the role of stress, trauma, and emotion regulation in contributing to 
chronic pain has been documented, there is no validated psychological treatment that 
directly targets pain patients’ unresolved stress and emotional avoidance. Lesserman 
(2005) reviewed treatments for PTSD and chronic pain and concluded that there is a 
need for exposure-based treatments for chronic pain patients with a PTSD diagnosis or 
with a trauma history. Although not much progress has been made since this 2005 
review, there are several other current interventions and techniques that provide 
support for the rationale of an emotional exposure or emotional processing type of 
treatment.  Also available is a potentially exciting and effective psychosocial treatment 
that helps patients recognize the key role of stress and emotions in their experience of 
chronic pain, and this dissertation will focus on the efficacy of this latter intervention.  
Written emotional disclosure, or expressive writing, a technique introduced by 
Pennebaker and Beall (1986), attempts to help participants resolve stress by writing 
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about their thoughts and feelings related to a traumatic event. Participants are typically 
randomized to writing about stress or trauma or to a control writing condition and write 
for several days. Originally, written emotional disclosure was tested in healthy 
populations and found to lead to significant improvements in health and functioning 
(Smyth, 1998). However, studies of the effects of writing about stress in chronic pain 
populations yielded less impressive results. Published studies show written emotional 
disclosure has weak effects on pain and other medical conditions (Broderick, Stone, 
Smyth, & Kaell, 2004; Frisina, Borod, & Lepore, 2004; Kelley, Lumley, & Leisen, 1997; 
Meads, Lyons, & Carroll, 2003; Norman, Lumley, Dooley, & Diamond, 2006). Although 
many of the studies do not seem to support the use of this technique for chronic pain, 
there have been two studies of written emotional disclosure in patients with fibromyalgia 
that have demonstrated positive results (Broderick, Junghaenel, & Schwartz, 2005; 
Gillis, Lumley, Mosley-Williams, Leisen, & Roehrs, 2006). The benefits found in patients 
with fibromyalgia may be attributed to the higher levels of unresolved stress found in 
this group than in patient groups with rheumatoid arthritis or headaches. It is possible 
that this technique is too brief and too limited in focus to produce positive effects. 
Furthermore, it requires participants to identify their key issues themselves, a skill that 
may be lacking in many participants. WED could still be useful as a component of a 
treatment targeting unresolved stress and emotions. 
Some of the largest support for an exposure-based treatment that targets 
unresolved stress and emotional avoidance stems from the literature on exposure-
based treatments for anxiety disorders. The use of imaginal and in vivo exposure 
without allowing the patients to avoid or escape the anxiety-provoking stimuli has shown 
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significant success for treating phobias, obsessive-compulsive disorder, and PTSD 
(Barlow & Lehman, 1996). Patients experience the feared and avoided stimulus—either 
an object, situation, or affective memories—in a safe and predictable environment with 
the support of the therapist. 
With the exception of several studies of written emotional disclosure, which show 
modest benefit for chronic pain, emotional-exposure based techniques have not been 
applied to chronic pain patients. However, Lumley and colleagues (2008) have 
developed an emotional exposure-based intervention to address the unresolved trauma 
identified in some patients with chronic pain. This treatment attempts to identify avoided 
experiences and encourage the patient to engage in exposure exercises so that 
emotional processing and relearning occur, leading to improved pain and health. 
Techniques such as education about experiential avoidance, written emotional 
disclosure, imaginal and in vivo exposure, and meta-communication among others are 
used to accomplish this purpose. Although this treatment is still under development and 
has not been validated in a controlled trial, a preliminary report evaluating the 
treatment’s efficacy for patients with fibromyalgia shows promising results (Lumley et 
al., 2008). In a sample of ten patients, there were significant improvements in 
unresolved stress symptoms, and marginally significant improvements in overall 
fibromyalgia symptoms, emotional distress, life satisfaction, and disability. Furthermore, 
reliable change indices showed that six of the 10 patients made at least moderate and 
meaningful changes.  
Much more research is needed on psychosocial treatments that target emotional 
avoidance that might underlie pain, especially pain found in people with somatoform 
16 
 
 
 
pain disorders (those without clear, contributing organic disease). Schubiner, a 
physician at Providence Hospital in Michigan, has created a 4-session group 
psychosocial treatment for patients with a diverse range of chronic pain problems. He 
was influenced by the work of Sarno (1998), who argued persuasively in the book, The 
Mindbody Prescription, that the many musculoskeletal pain problems that lack 
identifiable pathology are caused by repressed emotions. Sarno proposed that 
seemingly diverse pain problems are different manifestations of what he termed 
“tension myositis syndrome,” and should be treated by repudiating the medical 
diagnosis for the pain and accepting the psychological cause for the pain (repressed 
emotions). Schubiner has labeled the chronic pain problems in his treatment mind body 
syndrome (MBS)/tension myositis syndrome (TMS). His treatment uses readings, 
writing about emotions, meditation, and other techniques to help people identify, 
understand, and verbalize emotions related to stressful life events or emotional conflict. 
Schubiner’s treatment program, entitled, “Healing Yourself in Six Steps,” has these 
components: 
1. Recognizing the True Disorder (TMS): Repudiating the Physical 
2. Reading about TMS Each Day 
3. Writing Exercises: Write Away Your Symptoms 
4. Reflecting Exercises: Mindfulness Practice for Healing 
5. Reprogramming the Mind: Self-Talk and Training the Unconscious 
6. Rebuilding Your Life: Moving Towards the Light 
Many of Schubiner’s patients anecdotally report benefits including large 
improvements in pain. One controlled study has evaluated the effects of this treatment 
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compared to a wait-list control with a small sample of fibromyalgia patients (Hsu, 
Schubiner, Lumley, Stracks, Clauw, & Williams, in press). At a 6-month follow-up 
patients in the intervention group reported significantly lower pain severity, higher self-
reported physical functioning, and higher tender-point threshold compared to the control 
group. Additionally, nearly half of the patients in the intervention group had at least a 
30% reduction in pain severity compared to no patients in the control group. The effect 
of this treatment is still unknown outside of a randomized controlled trial with a broad 
range of chronic pain patients. Furthermore, research is still needed to identify 
moderators and mediators of this treatment protocol. 
Predictors of Treatment Outcome 
The presence of different types of chronic pain suggests that the “pain-patient 
homogeneity” myth should be discarded, and instead, factors that contribute to 
differential responding should be identified (Turk & Okifuji, 1998). Not all pain patients 
will have stressful life events or unresolved emotional conflict that is causing or 
exacerbating their pain.  Furthermore, even some patients who do have unresolved 
emotional issues will not respond to this intervention for various reasons, such as 
varying motivation, adherence, emotional abilities, and so on.  Most of the research on 
evaluating predictors of treatment response has been conducted with cognitive 
behavioral treatments, and few predictors of treatment success have been identified. In 
a study of CBT for temporomandibular disorder, patients with greater baseline 
somatization, depressive symptoms, number of pain sites, rumination, catastrophizing, 
and perceived stress had greater activity interference one year after treatment; 
however, none of these variables predicted change in pain (Turner, Holtzman, & Mancl, 
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2007). Even though this type of emotion-focused treatment has not been systematically 
evaluated, a review of the literature suggests several potential predictors of outcomes 
that may be relevant for a treatment that targets unresolved stress and poor emotion 
regulation, including baseline depression, stress, emotion regulation, and attitudes 
toward treatment.  
Alexithymia is one of the most researched emotion regulation predictors, and it 
appears that alexithymia usually predicts poorer outcomes of emotion-oriented 
treatments.  Some studies suggest that patients who are alexithymic respond more 
poorly to emotion-oriented interventions. A dissertation examining the effects of an 
internet-based emotional disclosure intervention in kidney transplant patients found that 
although patients who typically suppress their emotions benefitted more from 
disclosure, patients who were alexithymic benefited less (Posemato, 2008). Similarly, in 
a study of expressive talking in rheumatoid arthritis patients, alexithymia overall did not 
moderate outcome, however, higher scores on the subscale difficulty identifying feelings 
predicted increased disability in the expressive talking condition but not in the control 
condition (Kelley et al., 1997). The role of alexithymia as a predictor of worse outcome 
was also found in a sample of chronic pelvic pain patients (Norman et al., 2004). In this 
study, greater alexithymia scores predicted increased pain in the emotional disclosure 
group but not in the control.   
Even though alexithymia interfered with positive results in the prior studies, there 
are also examples of alexithymia predicting better outcomes. A study of emotional 
disclosure with university students found that the difficulty describing feelings subscale 
of alexithymia predicted improved physician illness visits, depression symptoms, and 
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sleep disturbance after written disclosure, but externally oriented thinking subscale 
predicted increased intrusion and hyperarousal symptoms. (Baikie, 2008). An 
examination of psychological responses and recovery following bladder surgery found 
that the alexithymia total score and the subscale difficulty identifying feelings predicted 
better outcome following emotional disclosure about the upcoming surgery as compared 
with controls (Solano, Donati, Pecci, Persichetti, & Colaci, 2003).  
Several factors regarding the participants’ thoughts and behavior during 
treatment have been found to predict treatment outcome. Participants who were most 
adherent to a treatment protocol had the greatest reduction in pain intensity (Basler & 
Hans, 1990). Treatment expectancy also has been found to predict outcome in cognitive 
behavioral treatments for chronic pain. Using a sample of patients with fibromyalgia and 
chronic low back pain from two randomized controlled trials, researchers found that 
pretreatment expectancy significantly predicted outcome both immediately and at a 12-
month follow-up (Goossens, Vlaeyen, Hidding, Kole-Snijders, & Evers, 2005). In 
addition to treatment expectancy, the perceived credibility of the treatment seems 
important as well. In another sample with chronic low back pain, treatment credibility 
was one of the strongest predictors of outcome regardless of which condition the 
participants were assigned (Kole-Snijders, et al. 1999). 
Preparing Patients for Treatment: Emotional Assessment  
As discussed above emotion regulation involves many components. The ability to 
express emotions and wishes/needs in an open manner and free from anxiety is an 
important manifestation of healthy emotional functioning, and one that is of interest for 
this dissertation. One method of categorizing relational emotions is to consider two 
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domains of autonomy/independence and attachment/dependence. The 
autonomy/independence domain consists of the ability to say no, to disagree with 
another’s opinion, and to communicate emotions like anger. The 
attachment/dependence domain consists of the ability to ask for help and to 
communicate gratitude and emotions such as guilt and love. Mental health is indicated 
by having healthy awareness and expression of both of these needs. 
Many patients, however, are not always able to identify avoided emotions nor do 
they recognize the impact of not expressing these emotions on other aspects of their 
lives, particularly their pain. Therefore, this dissertation will include an assessment 
intervention that is meant to help patients in this regard. 
 The format of this behavioral assessment was partially influenced by Finn’s work 
on therapeutic assessment (Finn, 1996; Finn, 2003). Finn considers assessment a 
semi-structured collaborative process that includes various assessment tools and what 
he has termed “assessment intervention sessions.” The goal of these sessions is to 
explore hypotheses and help the client reach new understanding. Finn often uses 
therapeutic assessment as a tool to help patients and therapists identify targets for 
therapy, particularly in situations when there is no improvement in treatment.  
Therapeutic assessment can be a useful tool to help prepare patients for 
treatment so that they will have better outcomes. One way to help prepare patients for 
an emotion-focused intervention such as the one that Schubiner offers, and which is the 
focus of this dissertation, is by making the avoided emotional and relational stimuli more 
salient. It would be ideal to help patients not only report their avoidance behavior with 
respect to autonomy/independence and attachment/dependence, but also to test the 
21 
 
 
 
avoidance behaviorally/experientially and then, importantly, have patients explore how 
these assessment data are linked with their core issues, needs, stressors, emotions, 
and pain. This emotional assessment approach is novel, but it may make patients more 
open or motivated for this type of treatment.  
Goals and Hypotheses  
 This study sought to further our understanding of emotion-focused treatments for 
patients with chronic pain that target unresolved stress and avoided emotions. Although, 
it has been demonstrated that patients with chronic pain have elevated stressful life 
events, emotional disorders, and poor emotion regulation, particularly avoidance or 
inhibition of key emotions, there is a dearth of research on treating these problems. The 
current study has three main goals to address the current limitations of the research. 
Evaluating treatment outcome.  The first goal of the current study was to evaluate 
Schubiner’s intervention by determining the effects of this intervention using a pre-test, 
post-test, and 3-month follow-up design. Although a randomized, controlled trial is 
considered the gold standard experimental design for determining efficacy, an initial 
step in the development of interventions is to evaluate change in an uncontrolled study. 
Calculating effect sizes as well as the number of people who benefit from the treatment 
are significant steps in the evaluation process. 
Hypothesis 1.  It was hypothesized that participating in this treatment would lead 
to improvements in chronic pain, pain-related disability, depression, and quality of life. 
Specifically, greater than one-third of the participants were hypothesized to improve 
after this intervention, which is the percentage of patients Turk found improved in a 
review of CBT treatments. 
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 Identifying Predictors of Treatment Outcome.  Given the evidence that not all 
patients respond to an intervention, the second goal of this study was to identify the 
factors that predict to successful outcomes in this intervention. Because this was a 
single group study, I could not examine actual moderators of treatment outcome, rather 
I examined several variables that may predict treatment outcome. As described above, 
patients with increased emotional disorders, stressful life events, and in some cases 
poor emotion regulation often have poorer treatment outcomes than pain patients 
without these characteristics. Therefore, these predictors were examined in this 
dissertation. Because treatment credibility and expectancy have predicted better 
outcomes in cognitive behavioral treatments, these factors were studied as well. 
Hypothesis 2.  It was hypothesized that higher baseline levels of depression, 
stressful life events, and poor emotion regulation skills would predict poorer outcomes 
of treatment. In addition, higher baseline ratings of treatment credibility and expectancy 
would predict better treatment outcomes than low treatment credibility and expectancy. 
Novel Behavioral Assessment of Emotional Ability.  The third goal of the current 
study was to develop and test an innovative type of emotional assessment method, in 
which the capacity to express emotions in an interpersonal context is assessed and the 
explored. Half of the participants were randomized to receive the additional emotional 
assessment. The goal of this assessment is to help prepare patients for treatment, and 
thus, it would be important to compare the two groups on outcome measures. 
 Hypothesis 3.  It was hypothesized that the participants randomly assigned to the 
novel behavioral assessment group would have better outcomes than the participants 
assigned to the standard assessment group. 
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CHAPTER 2 
 
METHOD 
Participants 
Participants were patients with chronic pain referred for the treatment program at 
Providence Hospital/St. John’s Health System. Participants reported chronic pain for at 
least 3 months duration as their primary symptom and had a pain problem in which 
substantial psychological factors are believed to contribute to the pain. Thus, pain 
patients included those with diagnoses of fibromyalgia (FM), irritable bowel syndrome 
(IBS), chronic low back pain (CLBP), temporomandibular disorder (TMD), myofascial 
pain syndrome (MPS), regional soft tissue pain syndrome (RSTPS), migraine 
headache, and tension-type headache.  Additional pain types (e.g., neck and shoulder, 
non-cardiac chest pain) were included if no clear peripheral organic etiology was 
suspected.  Patients were excluded who have pain disorders that are secondary to 
primary organic diseases (e.g., rheumatoid arthritis, inflammatory bowel disease, 
multiple sclerosis, lupus, sickle cell, cancer). Additional criteria for exclusion were the 
presence of current psychotic disorder, active suicidality or homicidality, current alcohol 
or drug dependence, dementia, mental retardation, or non-literacy in English—all of 
which were assessed by the evaluating physician. 
Procedure 
Patients referred to Schubiner’s treatment program were first screened over the 
telephone by Schubiner, and if deemed appropriate for treatment, were asked to 
purchase and read Sarno’s book, The Mindbody Prescription (1998). At this time, 
patients were mailed a set of background clinical measures, which included several pain 
and functioning measures analyzed in this study. Patients then met with Schubiner who 
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completed his standard evaluation, which included a medical history and physical 
examination to confirm inclusion criteria, rule out organic disease as the primary cause 
of the pain, and to help patients recognize the key role of stress and emotions in their 
experience of pain. Schubiner described the study to patients who signed up for his 
intervention and asked them for permission to be contacted by a researcher. These 
patients were contacted by one of the interviewers on the research team to schedule a 
meeting at Providence Hospital. Potential participants then completed the written 
informed consent document (See Appendix A), approved by the Human Investigation 
Committees of both Providence Hospital and Wayne State University. Upon completion 
of the informed consent, participants completed the pre-treatment assessment, the 
treatment, and the post-treatment and 3-month follow-up assessment. The pre-
treatment assessment and the treatment occurred at Providence Hospital. Initially, the 
post-treatment assessment was completed at the hospital and the 3-month follow-up 
was mailed to the participants. However, to reduce the burden on participants, the post-
treatment assessment was mailed to them as well. Participants were also compensated 
$90 for completing both assessments. They received $50 for completing the pre-
treatment assessment, $30 for completing the post-treatment assessment, and $10 for 
completing the 3-month follow-up. 
Seventy-three patients agreed to be contacted by the research team. A total of 
46 patients (63%) enrolled in the study. The remaining 37% did not participate for the 
following reasons: not interested (33%), did not participate in the treatment (22%), could 
not complete the baseline assessment before the start of treatment (19%), never 
returned the initial call (11%),  did not report pain as a primary problem (7%), unknown 
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(4%). At the time of data analysis, 4 participants had not returned follow-up data yet. 
Three of the participants (7%) dropped out of the study and did not provide any follow-
up data (one participant never took the treatment and two were for unknown reasons). 
Of the 39 participants who remained in the study and provided post-treatment data, 32 
(82%) provided 3-month follow-up data by the time of the analysis cut-off point. The 
sample averaged 51.05 years of age (SD = 15.52). The majority were women (76.1%) 
and Caucasian (91.3%). One participant each was African American, Middle Eastern, 
and Armenian. One participant did not identify an ethnicity. 
 Baseline assessment. Participants underwent a comprehensive psychosocial 
assessment which included completion of the outcome measures as well as stress and 
emotion regulation measures.  
 Experimental Emotional Assessment. Additionally, half of the participants were 
randomized to a group that included a novel emotional assessment that assessed the 
capacity to express emotions (Appendix B). The behavioral tests are comprised of two 
dimensions: dominance/autonomy and vulnerability/attachment. After the behavioral 
task, these participants then engaged in a discussion with the interviewer to explore 
links between their assessment and their histories, relationships, and pain to help 
prepare them for the treatment. The goal of this additional assessment was to help the 
participants create further awareness that may help identify key targets for the 
intervention. The behavioral assessment and the following discussion were completed 
by trained clinical graduate students. These sessions were also audio-taped; however, 
because this assessment is under development, these tapes will be analyzed at a future 
time. 
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 Psychosocial Treatment. This manualized intervention for mind-body syndrome 
(MBS)/tension myositis syndrome (TMS), created and provided by Howard Schubiner, 
M.D., involves a medical history and evaluation followed by tailored education about the 
patient’s unique pain onset and course, related to stressful life events.  This is designed 
to help patients recognize the key role of stress and emotions in their experience of 
pain. Patients then take a 4-session class that uses readings, writing about emotions, 
meditation, and other techniques to help people identify, understand, and verbalize 
emotions related to stress. Patients are instructed to complete daily homework 
assignments that include reading, writing, reflecting, reprogramming the mind, and 
rebuilding exercises, which typically total one hour each day. Classes usually include six 
to ten patients and occur once per week for four weeks at Providence Hospital. Each 
class is two hours. 
 Post-treatment Assessment. Following completion of the treatment, participants 
then completed the outcome measures again as well as measures of treatment 
engagement and adherence. As mentioned above, this assessment was initially 
completed in person at Providence Hospital but was later modified to be completed 
through the mail to reduce patient burden. 
 3-month Follow Up Assessment. Participants were mailed the primary outcome 
measures along with a pre-stamped, self-addressed envelope for returning the 
completed measures. 
Measures 
 There were two sets of measures in this study. At the baseline and post-
treatment psychosocial assessments, participants completed a standard set of clinical 
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outcome measures of adjustment: general health, pain, disability, psychological 
impairment, health care utilization, and attitudes toward treatment. At the baseline 
assessment only, participants also completed measures of stressful life events, 
emotional disorders, and emotion regulation, which served as potential predictor 
variables. Three of the outcome measures (Brief Pain Inventory, Center for 
Epidemiological Studies-Depression, and Satisfaction with Life) were given to the 
patients as part of routine clinical care and were completed prior to their initial medical 
evaluation. These measures were classified as “pre-baseline.” The remaining measures 
were classified as “baseline” when completed prior to treatment, as “post-treatment” 
when completed following completion of the treatment, and as “3-month follow-up” when 
completed at the 3-month follow-up assessment. 
 Primary Outcome Measures (Pre-baseline, Post-treatment, and Follow-up) 
 This dissertation assessed measures of general health, pain, disability, 
psychological impairment, and relationship problems. 
 Pain. Pain severity and pain-related disability were assessed using the Brief Pain 
Inventory (BPI; Daut, Cleeland, & Flanery, 1983). It assessed pain severity and pain 
interference with a 0 to 10 scale with 10 indicating greater severity. The pain severity 
items ask responders to rate their pain at the present moment in time and their worst, 
least, and average pain over the past week. For this study, these items were averaged 
to form a pain severity score. There are also 12 items that ask patients to rate how 
much their pain interfered with the activity listed. Because of an error printing the 
measure for this study, only the first 4 disability items were included (general activity, 
mood, mobility, and normal work), thus, these items were averaged to produce a pain-
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related disability score. Alpha in this sample was 0.90 for the pain severity items and 
0.86 for the disability items. 
 Depression. The Center for Epidemiological Studies Depression Scale (CES-D; 
Radloff, 1977) is a 20-item scale that measures depressive symptomatology. 
Participants are instructed to focus on depressed mood during the past week. This 
scale can be analyzed as a continuous measure of the relative degree of depressive 
symptoms, or it can be analyzed as a dichotomous measure using a cut-off score of 16, 
with scores above 16 indicating symptom levels suggestive of depression. Normative 
studies have found rates between 8.7% and 17.4% of women scoring above 16 on the 
CES-D (Knight, Williams, Mcgee & Olaman, 1997; Myers & Weissman, 1980; Roberts & 
Vernon, 1983). This measure was mailed to participants prior to the baseline 
assessment. Alpha in this sample was 0.91. 
 Life satisfaction.  The 5-item Satisfaction with Life Scale (Diener, Emmons, 
Larsen, & Griffin, 1985) was administered to measure one’s perception of general life 
satisfaction. Items were rated on a 1 to 7 scale and averaged; higher scores indicate 
greater global life satisfaction. Alpha in this sample was 0.85. 
Secondary Outcome Measures (Baseline, Post-treatment, and Follow-up) 
 Affective and sensory dimensions of pain.  The McGill Pain Questionnaire-Short 
Form (Melzak, 1997) was used to assess sensory and affective dimensions of pain that 
patients have experienced over the prior week. This 15-item self-report presents 11 
sensory adjectives and 4 affective adjectives rated on a 0 (none) to 3 (severe) scale. 
Discriminate validity is good with the demonstrated ability to distinguish various types of 
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pain, particularly acute versus chronic pain. Alpha in this sample was 0.86 for the 
sensory subscale and 0.78 for the affective subscale. 
 Chronic pain acceptance. The Chronic Pain Acceptance Questionnaire (CPAQ; 
McCracken, Vowles, & Eccleston, 2004) is a 20-item measure of pain-related 
acceptance. It has 2 subscales: Activity Engagement and Pain Willingness. The items 
are rated on a 0 (never true) to 6 (always true) scale with higher scores indicating 
greater acceptance. The CPAQ has good internal consistency, test-retest reliability, and 
validity (McCracken & Eccleston, 2005; McCracken et al., 2004, 2005). In this study, the 
total score was analyzed. Alpha in this sample was 0.88. 
 Stress cognitions and symptoms.  The Impact of Events Scale-Revised (Weiss & 
Marmar, 1997) is a 22-item scale that assesses symptoms of cognitive intrusions, 
cognitive avoidance, and hyperarousal during the past week with respect to a specific 
stressful event.  In this study, participants were instructed to identify the single most 
stressful event or experience that they have had and that continues to bother them, and 
to answer questions with respect to that event. The items are ranked on a 5-point scale 
(0 = not at all and 4 = extremely).  The scale has excellent internal consistency reliability 
(alpha = .96) and was found to correlate highly (r = .84) with the PTSD Checklist, a 
measure designed to assess DSM-IV symptoms of PTSD (Creamer, Bell, & Failla, 
2003). Participants identified a stressor upon completion of the baseline assessment 
and wrote it on the questionnaire and were instructed to complete the questionnaire with 
respect to that stressor at the post-treatment assessment. Alpha in this sample was 
0.93. 
30 
 
 
 
 General Emotional Distress. The Brief Symptom Inventory (BSI; Deragotis, 1975) 
was used to assess general emotional distress. The measures consists of 53 items 
rated on a 0 (not at all) to 5 (extremely) scale indicating level of distress about each 
symptom over the past 7 days. There are 3 global indices that broadly assess emotional 
distress (Global Severity Index (GSI), Positive Symptom Distress Index, and Positive 
Symptom Total) in addition to 9 subscales (Somatization, Obsession-Compulsion, 
Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic anxiety, Paranoid 
ideation and Psychoticism) that measure more specific symptoms of distress. The GSI 
is the most broadly used global score and has good test-retest reliability and validity 
(Conoley & Kramer, 1989; Deragotis, 1993; Derogatis, Rickels, & Rock, 1976). Only the 
GSI was analyzed for this study. Alpha in this sample was 0.93. 
 Predictor Measures (Baseline only) 
 Stressful Life Events.  The Life Stressor Checklist-Revised (Wolfe, Kimerling, & 
Brown, 1993; Wolfe, Kimerling, Brown, Chresman & Levin, 1996) contains 30 life stress 
items that meet DSM-IV-TR criteria for PTSD along with other stressful life experiences. 
The PTSD qualifying items also ask participants about their perception of harm or 
lethality, the intensity of their emotional reaction, and how much the event has affected 
them during the past year on a 1 to 5 scale. The non-PTSD questions only ask about 
the stressful experience’s effect during the past year. The Life Stressor Checklist-
Revised has demonstrated good criterion-related validity for PTSD in women and has 
performed adequately in populations with comorbid substance abuse and other 
psychological disorders (McHugo et al. 2005; Wolfe & Kimmerling, 1997).  The number 
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of stressful life events was summed and analyzed in this study along with the average 
level of distress associated with the stressful life events. 
 Alexithymia.  The Toronto Alexithymia Scale-20 (TAS-20; Bagby, Parker, & 
Taylor, 1994) assesses not only the global alexithymia construct, but also three facets 
of alexithymia: difficulty identifying feelings, difficulty describing feelings, and externally 
oriented thinking.  The scale has good reliability and is the most extensively validated 
measure of alexithymia (Bagby, Taylor, & Parker, 1994). Because the three subscales 
of the TAS-20 appear to have differential validity and tap different aspects of emotional 
regulation, the subscales were analyzed as well as the total score. Alpha in this sample 
was 0.86 for the total score, 0.81 for the difficulty identifying feelings subscale, 0.78 for 
the difficulty describing feelings subscale, and 0.56 for the externally oriented thinking 
subscale. 
 Emotional awareness. The 10-item version of the Levels of Emotional Awareness 
Scale (LEAS; Lane et al., 1990) was also administered.  This measure presents short, 
emotionally provocative vignettes, and participants are asked to write on a sheet of 
paper how they would feel as well as how the other person in the vignette would feel.  A 
scoring manual was used to rate these responses for the sophistication or complexity of 
their emotional language.  This measure has good internal consistency, very high 
interrater reliability, and predicts a range of criteria, including ability to identify emotions 
in faces, hemispheric dominance, and anterior cingulate gyrus activity (Lane et al., 
1995, 1996, 1998). Trained undergraduate students rated the responses using the 
scoring manual. 
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 Emotional expression conflict.  The 28-item Ambivalence Over Emotional 
Expression Questionnaire (AEQ; King & Emmons, 1990) was used to assess the 
experience of both desiring to express emotion and the conscious inhibition of doing so.  
The AEQ has high reliability and predicts negative mood and physical symptoms better 
than measures of the frequency of expressing emotion (King & Emmons, 1990). Alpha 
in this sample was 0.81. 
 Treatment Attitudes Survey.  This 10-item survey assessed participants’ thoughts 
regarding the rationale of the intervention. Participants rated their beliefs on a 5-point 
scale to questions like: “How much do you think that stressful life events or trauma 
cased your pain problem?”, “How much do you think that the source of your pain is in 
your mind?”, and “How much do you think that your mind can eliminate the pain?” Alpha 
in this sample was 0.84. 
In addition, because baseline levels of some of the outcome measures may 
predict who benefits from this treatment, several outcome measures were also explored 
as predictor variables. Specifically, baseline levels of depression (CES-D) and 
emotional distress (BSI) were tested as predictors.   
Data Analysis 
The data was checked for accuracy and frequency distributions of all items and 
scored variables were examined for outlier variables. Internal consistency (alpha) was 
assessed for all scales.  
 Hypothesis 1 
Several analyses were conducted to determine the effects of the intervention on 
chronic pain, pain-related disability, depression, and quality of life. First, a series of 
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paired-sample t-tests were used to determine the statistical significance of changes 
from baseline to post-treatment and baseline to the 3-month follow-up. Second, effect 
sizes were calculated to determine the magnitude of change at both of these time 
points. The effect sizes were calculated using Cohen’s d (post-treatment mean – 
baseline mean/baseline standard deviation). Values of 0.2, 0.5, and 0.8 are considered 
small, medium, and large respectively. Finally, individual patient outcomes were 
examined using the reliable change index (RCI), which indicates how much change 
occurred while accounting for measurement error across time. It is a ratio of the 
individual patient’s change score (follow-up value minus baseline value) to the sample’s 
standard error of the difference between the score. The formula for the standard error of 
measurement includes the baseline standard deviation and reliability (Cronbach’s 
alpha) of the measure. A separate RCI was calculated for both the post-treatment and 
the 3-month follow-up. Two cut-offs were used to determine the magnitude of individual 
change: 1.96 (p < .05), which represents a large effect but is very conservative, and 
0.50, which represents a moderate effect.   
 Hypothesis 2  
To identify predictors of treatment outcome, a series of partial correlations were 
used. Each predictor was correlated separately with each outcome measure change 
score; that is the difference between baseline and outcome (post minus pre values). 
The correlations were statistically adjusted for patients’ age and gender, because these 
variables were related to one or more of the predictors.  
Hypothesis 3 
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To determine the effects of the novel emotion communication assessment on 
outcomes, separate ANCOVAs examined whether the participants who received the 
therapeutic assessment did better on outcome measures than those who did not 
receive it. Group was used as the independent variable, and the change scores at post-
treatment and 3-months were used as the dependent variable. These analyses covaried 
age, which was marginally significant different between the two groups at baseline.  
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Chapter 3 
Results 
Estimating changes in outcome 
A set of paired-sample t-tests were conducted to evaluate the impact of the 
intervention on the participants’ pain, pain-related disability, pain acceptance, 
depression, general emotional functioning, and quality of life at both post-treatment and 
at the 3-month follow-up. In addition effect sizes were calculated using Cohen’s d to 
determine the magnitude of change on the outcome measures. The complete results of 
these t-tests and effect sizes are presented in Table 1.  
These analyses indicated that there were statistically significant improvements 
for the sample overall, for all measures at both post-treatment and at 3-month follow-up.  
Participants reported improved pain scores on multiple dimensions. First, they rated 
their pain on a 1-10 scale (BPI) significantly lower at both time points compared with 
baseline. The magnitude of this effect was large at both time points as well (d = 1.21 
and 1.16, respectively). Second, participants endorsed significantly fewer sensory and 
affective descriptions of pain at both time points. Interestingly, the magnitude of this 
difference was somewhat less strong than with the BPI measure of pain at both post-
treatment (d = 0.75) and 3-months (d = 0.78).  Participants also reported significantly 
less pain-related disability at both follow-up assessments with a very large effect size at 
both time points (d = 1.42 and 1.33, respectively). Additionally, participants not only 
reported less pain, they also reported significantly more acceptance of their chronic pain 
on a measure that assesses willingness to tolerate pain and to engage in activities 
regardless of pain. The magnitude of this change was also large at post-treatment (d = 
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0.97) and the 3-month follow-up assessment (d = 1.16). Improvement was also noted 
on multiple dimensions of mood and emotional functioning but with more variability in 
the magnitude of improvement than with the pain-related measures. First, participants 
reported significantly less depression on the CES-D at both follow-up time points 
compared with baseline. The magnitude of this change was large at post-treatment (d = 
1.04) and somewhat reduced but still large at the 3-month follow-up (d = 0.81).  The 
global severity index of the BSI, which measures general emotional distress, was also 
significantly reduced at follow-up. At post-treatment, this effect size was moderate to 
large (d = 0.75) but decreased to a small to moderate effect at 3 months (d = 0.47). 
Finally, participants reported significantly fewer symptoms of unresolved stress 
symptoms as reflected by cognitive intrusions, cognitive avoidance, and hyperarousal 
with respect to a specific stressful event. The moderate to large magnitude of change 
on this measure was maintained at both follow-up assessments (d = 0.75 and 0.78, 
respectively). 
On the final domain assessed, satisfaction with life, participants reported 
significantly more general satisfaction with life at post-treatment and at the 3-month 
follow-up.  However, the magnitude of change for this measure was smaller than the 
other outcome measures--the effect size was small to moderate at both time points (d = 
0.44 and 0.39, respectively). 
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TABLE 1. Baseline, Post-treatment, and Follow-up Data and Analyses of Change 
 
Outcome Measure 
 
Mean (SD) 
 
 
Change 
from 
baseline 
 
t 
 
p 
 
Effect Size (d) 
BPI Pain 
     Baseline 
     Post-treatment 
     3-month  
 
5.49 (1.91) 
3.18 (1.86) 
3.03 (1.83) 
 
 
-2.31 
-2.32 
 
 
-7.47 
-6.30 
 
 
< .01 
< .01 
 
 
-1.21 
-1.16 
BPI Disability 
     Baseline 
     Post-treatment 
     3-month 
 
6.01 (2.12) 
2.99 (2.26) 
3.07 (2.31) 
 
 
-3.02 
-2.81 
 
 
-8.34 
-5.46 
 
 
< .01 
< .01 
 
 
-1.42 
-1.33 
MPQ Sensory Pain 
     Baseline 
     Post-treatment 
     3-month 
 
10.09 (6.71) 
5.09 (4.92) 
6.20 (4.82) 
 
 
-5.01 
-4.85 
 
 
-5.16 
-3.85 
 
 
< .01 
<.01 
 
 
-0.75 
-0.69 
MPQ Affective Pain 
     Baseline 
     Post-treatment 
     3-month 
 
4.00 (3.52) 
1.27 (1.30) 
2.10 (2.78) 
 
 
-2.73 
-2.23 
 
 
-4.96 
-4.17 
 
 
< .01 
< .01 
 
 
-0.78 
-0.62 
Pain Acceptance 
     Baseline 
     Post-treatment 
     3-month 
 
47.56 (16.90) 
63.90 (18.56) 
65.74 (17.96) 
 
 
16.33 
20.00 
 
 
5.87 
4.94 
 
 
< .01 
< .01 
 
 
0.97 
1.16 
Depression 
     Baseline 
     Post-treatment 
     3-month 
 
27.69 (12.20) 
15.00 (10.76) 
18.31 (13.07) 
 
 
-12.69 
-10.27 
 
 
-6.33 
-4.60 
 
 
< .01 
< .01 
 
 
-1.04 
-0.81 
General Emotional 
Symptoms 
     Baseline 
     Post-treatment 
     3-month 
 
 
57.54 (32.29) 
33.16 (26.46) 
45.00 (37.35) 
 
 
 
-24.37 
-16.05 
 
 
 
-6.76 
-3.19 
 
 
 
< .01 
< .01 
 
 
 
-0.75 
-0.47 
Unresolved Stress 
     Baseline 
     Post-treatment 
     3-month 
 
29.17 (19.20) 
14.68 (10.19) 
14.83 (12.74) 
 
 
-14.49 
-15.70 
 
 
-5.61 
-5.18 
 
 
< .01 
< .01 
 
 
-0.75 
-0.78 
Satisfaction with Life  
     Baseline 
     Post-treatment 
     3-month 
 
     3.21 (1.51) 
3.87 (1.53) 
3.74 (1.60) 
 
 
0.66 
0.61 
 
 
4.01 
2.64 
 
 
< .01 
< .05 
 
 
0.44 
0.39 
Note. Paired sample t-tests and effect size calculation included only those participants who provided data at that 
follow-up point. N = 38 at post-treatment and 30 at 3-months for the BPI, Depression, Unresolved Stress, and 
Satisfaction with Life measures. N = 37 at post-treatment and 30 at 3-months for the McGill. N = 39 at post-treatment 
and 31 at 3-months for Pain Acceptance and General Emotional Symptoms. 
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Individual Responder Rates 
Individual patient outcomes were also examined using the reliable change index 
(RCI), which indicates how much change occurred while accounting for measurement 
error across time. These results are presented in Table 2. 
On the Brief Pain Inventory, 86.9% of the participants showed at least moderate 
effects, with 65.8% of the sample obtaining large effects at post-treatment. Similar 
effects were found at the 3-month follow-up assessment; 83.8% showed at least 
moderate effects, with 60% of the sample obtaining large effects. The disability items of 
the BPI led to similar results as well; 82% of the participants showed at least moderate 
effects, with 66% of the sample obtaining large effects. At 3 months, 80% showed at 
least moderate effects, with 50% of the sample obtaining large effects.  
Consistent with the pattern noted above with statistical significance of the 
changes, there were fewer participants demonstrating reliable change on the McGill 
Pain Questionnaire than the Brief Pain Inventory. An examination of scores on the 
Sensory subscale of the McGill Pain Questionnaire showed that 59% had at least 
moderate effects, with nearly 30% of the sample obtaining large effects at post-
treatment. Nearly identical outcomes were found at 3 months with 60% obtaining 
moderate effects, and 30% of the sample obtaining large effects. Slightly less individual 
change was found for the Affective subscale. At post-treatment, 51% showed at least 
moderate effects, with 22% of the sample obtaining large effects. This level of 
improvement was maintained at 3 months with 50% showing at least moderate effects, 
and 17% of the sample obtaining large effects.   
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There was substantial improvement in pain acceptance at both follow-up 
assessments. At post-treatment, 74% showed at least moderate effects, with 41% of the 
sample obtaining large effects. At 3 months, 74% showed at least moderate effects with 
45% of the sample obtaining large effects. 
Comparable effects were found for the measures of emotional functioning as with 
the pain-related measures. On the depression measure, 76% of the participants showed 
at least moderate effects at post-treatment, with 58% of the sample obtaining large 
effects. Similarly substantial effects were noted at 3 months as well with 77% showing 
at least moderate effects. Of the participants, 37% obtained large effects. Regarding 
general levels of emotional distress, 77% showed at least moderate effects at post-
treatment, with nearly half of the sample (46%) obtaining large effects. At 3 months, 
68% still showed at least moderate effects with approximately 1/3 of the participants 
(32%) obtaining large effects. On a measure of unresolved stress symptoms, 71% 
showed at least moderate effects with 53% of the sample obtaining large effects. These 
effects were slightly better at 3 months with 77% showing at least moderate effects and 
57% obtaining large effects.  
Also similarly to the patterns on the t-tests and effect sizes, there were fewer 
positive responses for satisfaction with life than for the other outcome measures. . At 
post-treatment, 45% showed at least moderate effects with 13% of the participants 
obtaining large effects. At the 3 month follow-up, 47% showed at least moderate effects 
with 20% of the sample at this point obtaining large effects.  
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Table 2. Reliable Change Index 
 
 
No Effect 
n (%) 
Moderate (but not 
large) Effect 
n (%) 
Large Effect 
n (%) 
BPI Pain 
     Post-treatment (N = 38) 
     3-month (N = 30) 
 
5 (13.2) 
5 (16.7) 
 
8 (21.1%) 
7 (23.3%) 
 
25 (65.8) 
18 (60.0) 
BPI Disability 
     Post-treatment (N = 38) 
     3-month (N = 30) 
 
7 (18.4) 
6 (20.0) 
 
6 (15.8) 
9 (30.0) 
 
25 (65.8) 
15 (50.0) 
MPQ Sensory Pain 
     Post-treatment (N = 37) 
     3-month (N = 30) 
 
15 (40.5) 
12 (40.0) 
 
11 (29.7) 
9 (30.0) 
 
11 (29.7) 
9 (30.0) 
MPQ Affective Pain 
     Post-treatment (N = 37) 
     3-month (N = 30) 
 
18 (48.6) 
15 (50.0) 
 
11 (29.7) 
10 (33.3) 
 
8 (21.6) 
5 (16.7) 
Pain Acceptance 
     Post-treatment (N = 39) 
     3-month (N = 31) 
 
10 (25.6) 
8 (25.8) 
 
13 (33.3) 
9 (29.0) 
 
16 (41.0) 
14 (45.2) 
Depression 
     Post-treatment (N = 38) 
     3-month (N = 30) 
 
9 (23.7) 
7 (23.3) 
 
7 (18.4) 
12 (40.0) 
 
22 (57.9) 
11 (36.7) 
General Emotional Symptoms 
     Post-treatment (N = 39) 
     3-month (N = 31) 
 
9 (23.1) 
10 (32.3) 
 
12 (30.8) 
11 (35.5) 
 
18 (46.2) 
10 (32.3) 
Unresolved Stress 
     Post-treatment (N = 38) 
     3-month (N = 30) 
 
11 (28.9) 
7 (23.3) 
 
7 (18.4) 
6 (20.0) 
 
20 (52.6) 
17 (56.7) 
Satisfaction with Life 
     Post-treatment (N = 38) 
     3-month (N = 30) 
 
21 (55.3) 
16 (53.3) 
 
12 (31.6) 
8 (26.7) 
 
5 (13.2) 
6 (20.0) 
Note. Large effect = cut off of 1.96; Moderate effect = .50. 
 
Predicting changes in outcome 
Correlations among the predictor variables. The correlations among the predictor 
variables are presented in Table 3. An examination of the correlation matrix reveals 
several domains of predictor variables. With the exception of a couple of scattered 
significant correlations, depression, the two stress items, and attitudes toward treatment 
each represent a separate predictor domain, whereas the emotion regulation measures 
(alexithymia, ambivalence over emotional expression, levels of emotional awareness, 
and communicating thoughts and feelings questionnaire) represent another domain of 
predictors. Aside from the very high correlations among the difficulty identifying feelings, 
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the difficulty describing feelings subscales and the total alexithymia score, the majority 
of the correlations do not suggest any redundant measures. 
 
Table 3. Intercorrelations among predictor variables 
 CESD TAS20 DIF DDF EOT AEQ LEAS CTF-
A 
CTF-
V 
LSCRsum LSCRdis TASpre 
CESD  .27 .34 .20 .09 .41 .16 -.08 -.20 -.07 .26 -.26 
TAS20   .87 .87 .69 .69 -.31 -.48 -.44 -.05 .29 -.07 
DIF    .70 .36 .75 -.09 -.34 -.43 .13 .33 -.01 
DDF     .43 .65 -.37 -.48 -.30 -.13 .17 -.13 
EOT      .21 -.34 -.36 -.37 -.15 .17 -.04 
AEQ       -.15 -.52 -.36 .10 .38 -.14 
LEAS        .28 .20 .44 .22 .19 
CTFQ-A         .48 -.17 -.23 .32 
CTFQ-V          .01 -.12 .29 
LSCRsum           .31 .04 
LSCRdis            .04 
Note. CESD = Center for Epidemiological Studies-Depression; TAS20 = Toronto Alexithymia Scale total score; DIF = 
TAS20 Difficulty Identifying Feelings; DDF = TAS20 Difficulty Describing Feelings; EOT = TAS20 Externally Oriented 
Thinking; AEQ = Ambivalence Over Emotional Expression; LEAS = Levels of Emotional Awareness Scale; CTF-A = 
Communicating Thoughts and Feelings Questionnaire Assertive Subscale; V = Vulnerability Subscale; LSCRsum = 
Life Stressor Checklist Revised Number of Stressful Life Events; LSCRdis = Average Distress Associated with 
Stressors; TASpre = Treatment Attitudes Survey 
p < .05 when r ≥ ± .30; p < .01 when r ≥ ± .37 
 
A series of partial correlations were used to explore the relationships between 
baseline measures of depression, emotion regulation, stress, and attitudes toward 
treatment, and the change scores for the outcome measures for both the post-treatment 
and the 3-month follow-up. The demographic variables of age and gender were 
associated with some of the predictor variables. Thus, these correlations were 
controlled for age and gender to eliminate any potential confounds of these 
relationships.  
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Baseline Depression 
Partial correlations were examined between baseline levels of depression and 
change in the outcome measures. Overall, baseline depression was a significant 
predictor of change in outcome across several domains, and these values are 
presented in Table 4. First, with respect to pain-related outcome measures, depression 
failed to predict changes in pain as measured by the Brief Pain Inventory at either time 
point; however, it predicted change in both the sensory and affective subscales of the 
McGill Pain Questionnaire at the post-treatment assessment. Specifically, greater 
depression at baseline significantly predicted a greater reduction in the affective 
dimension of pain and marginally did so in the sensory dimension of pain. This 
relationship was not maintained at the 3-month follow up. Regarding pain-related 
disability, greater baseline depression significantly predicted a greater reduction in 
disability at post-treatment and marginally did so at 3 months. Finally, baseline 
depression failed to predict changes in pain acceptance at both time points. 
With respect to the prediction of changes in emotional functioning, baseline 
depression was, not surprisingly, related to change in depression and general emotional 
distress. Specifically, greater depression at baseline significantly predicted more 
improvement in depression at both post-treatment and 3 months, whereas it predicted 
more improvement in general levels of emotional distress only at post-treatment. 
Greater baseline depression also predicted a greater reduction in unresolved stress 
symptoms at post-treatment but not at the 3-month follow-up. Finally regarding 
satisfaction with life, greater baseline depression predicted more satisfaction with life at 
post-treatment. This relationship was not maintained at 3 months. 
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Table 4. Partial correlations (controlling for gender and age) between baseline 
depression and changes in outcome measures (post minus pre) 
 Depression 
 
Pain 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
-.19 
-.30 
Pain-related Disability 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
-.32† 
-.40* 
Sensory Pain 
     Post-treatment (n = 37) 
     3-month (n = 30) 
 
-.33† 
-.17 
Affective Pain 
     Post-treatment (n = 37) 
     3-month (n = 30) 
 
-.50** 
-.21 
Pain Acceptance 
     Post-treatment (n = 39) 
     3-month (n = 31) 
 
.13 
.19 
Depression 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
-.68** 
-.48** 
General Emotional Distress 
     Post-treatment (n = 39) 
     3-month (n = 31) 
 
-.53** 
-.28 
Unresolved Stress Symptoms 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
-.34* 
-.06 
Satisfaction with Life 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.37* 
.15 
Note. †p < .10. *p < .05. **p < .01 
 
Baseline levels of stress 
Stress at baseline demonstrated predictive ability of change in outcome 
measures across domains. These values are presented in Table 5. Greater levels of 
distress associated with stressful life events at baseline marginally predicted less 
improvement in pain-related disability at post-treatment but not at the 3-month follow-up. 
In contrast, greater levels of distress at baseline significantly predicted more reduction 
in affective dimensions of pain at post-treatment, and number of stressful life events at 
baseline marginally predicted more improvement in chronic pain acceptance at post-
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treatment. Similarly, both greater number of stressful life events and greater distress 
associated with stressful life events at baseline significantly predicted more reduction in 
unresolved stress symptoms at post-treatment. At 3 months, only number of stressful 
life events remained a significant predictor. Baseline levels of stress failed to predict 
changes in pain on the BPI, depression, general emotional distress, and satisfaction 
with life. 
Table 5. Partial correlations (controlling for gender and age) between baseline levels of 
stress and changes in outcome measures 
 Stress 
 
 Number of Stressful Life Events 
 
Associated Distress 
Pain 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
-.04 
.05 
 
.11 
.18 
Pain-related Disability 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.02 
.21 
 
.30† 
.26 
Sensory Pain 
     Post-treatment (n = 37) 
     3-month (n = 30) 
 
-.09 
.01 
 
-.24 
-.02 
Affective Pain 
     Post-treatment (n = 37) 
     3-month (n = 30) 
 
-.08 
-.11 
 
-.40* 
-.29 
Pain Acceptance 
     Post-treatment (n = 39) 
     3-month (n = 31) 
 
.28† 
.12 
 
.27 
.12 
Depression 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.01 
-.09 
 
.03 
.09 
General Emotional Distress 
     Post-treatment (n = 39) 
     3-month (n = 31) 
 
-.15 
-.12 
 
-.11 
.08 
Unresolved Stress Symptoms 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
-.36* 
-.47* 
 
-.44** 
-.32 
Satisfaction with Life 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.25 
.28 
 
.11 
-.02 
Note. †p < .10. *p < .05. **p < .01 
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Alexithymia 
The total score of alexithymia, along with the separate subscales, demonstrated 
some predictive validity with respect to change in the outcome measures. These values 
are presented in Table 6. Overall, alexithymia failed to predict changes in pain as 
measured by both the BPI and the MPQ. However, greater baseline levels of the 
difficulty identifying feelings subscale marginally predicted less improvement in pain on 
the BPI at 3 months. In contrast, greater baseline levels of the difficulty describing 
feelings subscale marginally predicted more improvement in the affective dimension of 
pain on the MPQ at post-treatment. Alexithymia failed to predict changes in pain-related 
disability.  Finally for the pain-related measures, greater levels of alexithymia at baseline 
marginally predicted more improvement in chronic pain acceptance at post-treatment. 
Examining the predictive ability of the alexithymia subscales reveals that, specifically, 
greater levels of the difficulty identifying feelings subscale significantly predicted more 
improvement in pain acceptance. Interestingly, while greater levels of difficulty 
identifying feelings predicted less improvement in pain on a 1-10 scale, it predicted 
more improvement in chronic pain acceptance. 
With respect to the outcome measures of emotional functioning, baseline levels 
of alexithymia failed to predict changes in depression and general emotional distress at 
both time points. However, greater levels of alexithymia at baseline significantly 
predicted a greater reduction in unresolved stress symptoms at post-treatment. Both the 
difficulty identifying feelings and the difficulty describing feelings subscales significantly 
predicted this change. At the 3-month follow-up, only the difficulty identifying feelings 
subscale significantly predicted a greater reduction in unresolved stress symptoms, and 
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the difficulty describing feelings subscale marginally did so. On the final measure, 
satisfaction with life, there was only one marginally significant prediction found between 
the difficulty describing feelings subscale of alexithymia and satisfaction with life. 
Specifically, greater levels of difficulty describing feelings marginally predicted less 
improvement in satisfaction at the 3-month follow-up. The externally oriented thinking 
subscale of alexithymia failed to predict any changes in outcome. 
Table 6. Partial correlations (controlling for gender and age) between baseline 
alexithymia and changes in outcome measures 
 Alexithymia 
 
 Total 
Alexithymia 
 
Difficulty 
Identifying 
Feelings 
Difficulty 
Describing 
Feelings 
Externally 
Oriented 
Thinking 
Pain 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.18 
.20 
 
.22 
.33† 
 
.08 
.04 
 
.13 
.08 
Pain-related Disability 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.22 
.14 
 
.24 
.27 
 
.12 
-.10 
 
.16 
.17 
Sensory Pain 
     Post-treatment (n = 37) 
     3-month (n = 30) 
 
-.20 
.05 
 
-.11 
.12 
 
-.21 
-.11 
 
-.18 
.13 
Affective Pain 
     Post-treatment (n = 37) 
     3-month (n = 30) 
 
-.23 
-.11 
 
-.23 
-.18 
 
-.32† 
-.24 
 
.04 
.24 
Pain Acceptance 
     Post-treatment (n = 39) 
     3-month (n = 31) 
 
.28† 
.10 
 
.36* 
.06 
 
.17 
.21 
 
.12 
-.06 
Depression 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.04 
.21 
 
-.03 
.19 
 
.01 
.13 
 
.13 
.17 
General Emotional Distress 
     Post-treatment (n = 39) 
     3-month (n = 31) 
 
-.14 
-.11 
 
-.23 
-.10 
 
-.17 
-.27 
 
.10 
.16 
Unresolved Stress Symptoms 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
-.41* 
-.31 
 
-.55** 
-.53** 
 
-.41† 
-.33† 
 
.02 
.20 
Satisfaction with Life 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
-.03 
-.28 
 
.02 
-.25 
 
-.16 
-.35† 
 
.09 
.01 
Note. †p < .10. *p < .05. **p < .01 
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Ambivalence over Emotional Expression 
In general, ambivalence over emotional expression demonstrated predictive 
ability across the domains of outcome measures. These values are presented in Table 
7. With respect to the Brief Pain Inventory, baseline ambivalence failed to predict 
changes in pain and pain-related disability.  However, greater baseline levels of 
ambivalence about expressing emotions significantly predicted greater reductions in 
both sensory and affective dimensions of pain at post-treatment and a greater reduction 
in the affective dimension of pain at 3 months. Additionally, greater levels of baseline 
ambivalence significantly predicted more improvement in chronic pain acceptance at 
post-treatment but not at 3 months. 
With respect to the measures of emotional functioning, ambivalence over 
emotional expression failed to predict changes in depression at follow-up.  Greater 
levels of ambivalence at baseline significantly predicted more improvement in general 
emotional distress symptoms at post-treatment and marginally so at 3 months. It also 
significantly predicted a greater reduction in unresolved stress symptoms at both time 
points. Finally, ambivalence over expressing emotions failed to predict changes in 
satisfaction with life. 
 
 
 
 
 
 
48 
 
 
 
Table 7. Partial correlations (controlling for gender and age) between baseline 
ambivalence over emotional expression and changes in outcome measures 
 Ambivalence Over Emotional 
Expression 
 
Pain 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.03 
.25 
Pain-related Disability 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.15 
.14 
Sensory Pain 
     Post-treatment (n = 37) 
     3-month (n = 30) 
 
-.43* 
-.19 
Affective Pain 
     Post-treatment (n = 37) 
     3-month (n = 30) 
 
-.53** 
-.43* 
Pain Acceptance 
     Post-treatment (n = 39) 
     3-month (n = 31) 
 
.36* 
.17 
Depression 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.12 
-.07 
General Emotional Distress 
     Post-treatment (n = 39) 
     3-month (n = 31) 
 
-.42* 
-.32† 
Unresolved Stress Symptoms 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
-.54** 
-.51** 
Satisfaction with Life 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.00 
-.17 
Note. †p < .10. *p < .05. **p < .01 
 
Levels of Emotional Awareness 
Baseline levels of emotional awareness only demonstrated predictive ability on 
two measures. These values are presented in Table 8. It failed to predict changes in 
any of the pain-related measures, depression, and general emotional distress. Greater 
levels of emotional awareness at baseline marginally predicted a greater reduction in 
unresolved stress symptoms at the 3-month follow-up. There was also a marginally 
significant prediction found between emotional awareness and satisfaction with life. 
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Greater levels of emotional awareness marginally predicted more satisfaction at both 
post-treatment and 3 months. 
Table 8. Partial correlations (controlling for gender and age) between baseline levels of 
emotional awareness and changes in outcome measures 
 Levels of Emotional Awareness 
 
Pain 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.05 
-.10 
Pain-related Disability 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.08 
.07 
Sensory Pain 
     Post-treatment (n = 37) 
     3-month (n = 30) 
 
.24 
-.02 
Affective Pain 
     Post-treatment (n = 37) 
     3-month (n = 30) 
 
.26 
.08 
Pain Acceptance 
     Post-treatment (n = 39) 
     3-month (n = 31) 
 
.18 
.08 
Depression 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.11 
-.12 
General Emotional Distress 
     Post-treatment (n = 39) 
     3-month (n = 31) 
 
-.01 
-.11 
Unresolved Stress Symptoms 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.05 
-.36† 
Satisfaction with Life 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.28† 
.31† 
Note. †p < .10. *p < .05. **p < .01 
 
Communicating Thoughts and Feelings 
The Communicating Thoughts and Feelings Questionnaire also only 
demonstrated predictive ability of change in two measures. These values are presented 
in Table 9. Both the assertive and the vulnerability subscales failed to predict changes 
in pain and pain-related disability on the BPI along with changes in chronic pain 
acceptance. On the MPQ, greater baseline levels of assertive ability in communicating 
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thoughts and feelings marginally predicted less improvement in the sensory dimension 
of pain at post-treatment. Thus, surprisingly, participants who rated themselves as more 
assertive at baseline actually reported marginally more sensory pain at outcome than 
those who rated themselves as less assertive. A similar prediction was found for 
unresolved stress symptoms. Greater levels of assertive ability at baseline significantly 
predicted less reduction in unresolved stress symptoms at post-treatment, and greater 
levels of ability communicating vulnerable thoughts and feelings marginally predicted 
less reduction in unresolved stress symptoms at post-treatment. These relationships 
were not maintained at 3 months. Communicating thoughts and feelings failed to predict 
changes in depression, general emotional distress, and satisfaction with life. 
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Table 9. Partial correlations (controlling for gender and age) between baseline levels of 
communicating thoughts and feelings and changes in outcome measures 
 Communicating Thoughts and Feelings 
 
 Assertive 
 
Vulnerability 
Pain 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
-.05 
-.26 
 
-.14 
-.17 
Pain-related Disability 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.02 
-.22 
 
-.02 
-.21 
Sensory Pain 
     Post-treatment (n = 37) 
     3-month (n = 30) 
 
.34† 
-.02 
 
.16 
-.05 
Affective Pain 
     Post-treatment (n = 37) 
     3-month (n = 30) 
 
.17 
.08 
 
-.12 
-.18 
Pain Acceptance 
     Post-treatment (n = 39) 
     3-month (n = 31) 
 
-.16 
-.04 
 
-.07 
-.05 
Depression 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.12 
.09 
 
.00 
.07 
General Emotional Distress 
     Post-treatment (n = 39) 
     3-month (n = 31) 
 
.22 
.20 
 
.21 
.16 
Unresolved Stress Symptoms 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.40* 
.20 
 
.35† 
.27 
Satisfaction with Life 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
-.04 
-.10 
 
-.28 
-.21 
Note. †p < .10. *p < .05. **p < .01 
 
Attitudes Toward Treatment 
The measure of attitudes toward treatment was predictive of change in only one 
outcome measure. These values are presented in Table 10. Greater levels of positive 
feelings toward the treatment marginally predicted more improvement in chronic pain 
acceptance at post-treatment, but not at the 3-month follow-up. Attitudes toward 
treatment failed to predict changes in pain, pain-related disability, measures of emotion 
functioning, and satisfaction with life. 
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Table 10. Partial correlations (controlling for gender and age) between baseline 
attitudes toward treatment and changes in outcome measures 
 Attitudes Toward Treatment 
 
Pain 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
-.27 
-.15 
Pain-related Disability 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
-.00 
.06 
Sensory Pain 
     Post-treatment (n = 37) 
     3-month (n = 30) 
 
.08 
.06 
Affective Pain 
     Post-treatment (n = 37) 
     3-month (n = 30) 
 
.13 
-.03 
Pain Acceptance 
     Post-treatment (n = 39) 
     3-month (n = 31) 
 
.32† 
.09 
Depression 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.14 
.24 
General Emotional Distress 
     Post-treatment (n = 39) 
     3-month (n = 31) 
 
.07 
.19 
Unresolved Stress Symptoms 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.12 
-.03 
Satisfaction with Life 
     Post-treatment (n = 38) 
     3-month (n = 30) 
 
.11 
.05 
Note. †p < .10. *p < .05. **p < .01 
 
 
Evaluating effects of emotional assessment on outcome 
The demographic and baseline variables were examined to determine any 
differences between the participants who received the novel emotional communication 
assessment and those did not receive the assessment. There were no significant 
differences between the groups on age, gender, and ethnicity, although age showed 
some trend of difference between the two groups, F(1, 43) = 1.78, p = .19. Those who 
received the assessment were slightly older than those who did not. See Table 11 for 
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the demographics of each group. There were also no significant differences between 
groups on the baseline outcome measures. These analyses are presented in Table 12. 
A series of ANCOVA’s were conducted to determine whether the participants 
who received the novel emotional communication assessment had greater improvement 
on the outcome measures than participants who did not receive the assessment. Group 
was used as the independent variable, and the change scores at post-treatment and 3-
months were used as the dependent variable. Because age was slightly significantly 
different between the two groups it was entered as a covariate for these analyses. 
These analyses were conducted separately for the post-treatment and 3-month follow-
up assessments. At post-treatment and at the 3-month follow-up, the ANCOVA’s 
revealed no significant differences between the two groups. There was one trend for 
significance in the opposite direction than hypothesized for satisfaction with life at 3 
months. Participants in the group receiving the novel assessment tended to report less 
satisfaction with life than the participants who did not receive the assessment, F(1, 27) = 
3.48, p = .07. The complete results of the baseline, post-treatment, and 3-month follow-
up data and the ANCOVAs are presented in Table 12. 
 
Table 11. Comparison of Demographic Variables Between Those Who Received The 
Emotion Assessment and Those Who Did Not.  
 
 
 Assessment 
(n =22 ) 
No Assessment 
(n = 24) 
F/χ2 p 
Age (years) M (SD) 54.29 (14.60) 48.09 (16.06) 1.78 .19 
Gender 
     Female 
     Male 
 
n (%) 
n (%) 
 
17 (77.27%) 
5 (22.72%) 
 
18 (75.00%) 
6 (25.00%) 
 
.03 
 
.86 
Ethnicity 
     Caucasian 
     African American 
     Middle Eastern 
     Unknown 
 
n (%) 
n (%) 
n (%) 
n (%) 
 
19 (90.48%) 
0 (0.00%) 
1 (4.76%) 
1 (4.76%) 
 
23 (95.83%) 
1 (4.17%) 
0 (0.00%) 
0 (0.00%) 
 
.52 
 
.47 
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Note. Chi-square analysis for ethnicity was analyzed comparing Caucasian to the other ethnicities 
combined due to the small numbers in the other cells. 
 
 
Table 12. Baseline, Post-treatment, and Follow-up Data and Analyses of Change by 
Group. 
 
 
Assessment 
 
No Assessment 
 
F p 
 n M (SD)  Change 
Score 
n M (SD)  Change 
Score 
  
BPI Pain 
     Baseline  
     Post-treatment  
     3-month  
 
21 
19 
15 
 
5.35 (2.07) 
3.16 (1.81) 
3.49 (1.93)  
 
 
-2.19 
-1.86 
 
24 
20 
16 
 
5.23 (1.91)  
3.21 (1.91) 
2.72 (1.68 
 
 
-2.02 
-2.51 
 
.04 
.21 
.03 
 
.85 
.65 
.87 
BPI Disability 
     Baseline  
     Post-treatment  
     3-month  
 
21 
19 
15 
 
5.92 (2.20)  
3.11 (2.04)  
3.85 (2.68) 
 
 
-2.81 
-2.07 
 
24 
20 
16 
 
5.60 (2.23) 
2.93 (2.46) 
2.40 (1.62) 
 
 
-2.67 
-3.20 
 
.23 
.16 
.04 
 
.63 
.69 
.84 
MPQ Sensory Pain 
     Baseline  
     Post-treatment  
     3-month  
 
22 
18 
15 
 
10.40 (7.10)  
5.79 (6.34)  
8.11 (5.19) 
 
 
-4.61 
-2.29 
 
23 
20 
16 
 
9.90 (5.68) 
5.15 (4.42) 
4.46 (3.61) 
 
 
-4.75 
-5.44 
 
.07 
.31 
.48 
 
.80 
.58 
.50 
MPQ Affective Pain 
     Baseline  
     Post-treatment  
     3-month  
 
22 
18 
15 
 
4.50 (3.76) 
1.22 (1.26)  
2.73 (3.13)  
 
 
-3.28 
-1.77 
 
23 
20 
16 
 
3.65 (2.92) 
1.60 (1.85) 
1.56 (2.28) 
 
 
-2.05 
-2.09 
 
.72 
.69 
.03 
 
.40 
.41 
.86 
Pain Acceptance 
     Baseline  
     Post-treatment  
     3-month  
 
22 
19 
15 
 
50.68 (17.39)  
64.47 (18.76)  
63.20 (18.74)  
 
 
13.79 
12.52 
 
24 
20 
16 
 
46.25 (16.78) 
63.35 (18.84) 
68.13 (17.45) 
 
 
17.10 
21.88 
 
.77 
.46 
.60 
 
.38 
.50 
.45 
Depression 
     Baseline  
     Post-treatment  
     3-month  
 
21 
19 
15 
 
27.35 (12.15) 
14.26 (9.83)  
22.74 (12.83)  
 
 
-13.09 
-4.61 
 
24 
20 
16 
 
27.72 (12.42) 
15.10 (11.88) 
13.50 (11.81) 
 
 
-12.62 
-14.22 
 
.01 
.01 
2.19 
 
.92 
.91 
.15 
General Emotional 
Distress 
     Baseline 
     Post-treatment 
     3-month 
 
 
22 
19 
15 
 
 
59.10 (32.88) 
33.93 (26.01) 
51.33 (43.94) 
 
 
 
-25.17 
-7.77 
 
 
24 
20 
16 
 
 
57.54 (30.39) 
32.42 (27.53) 
39.06 (39.66) 
 
 
 
-25.12 
-18.48 
 
 
.03 
.23 
.11 
 
 
.87 
.64 
.74 
Unresolved Stress 
     Baseline 
     Post-treatment 
     3-month 
 
22 
19 
14 
 
29.43 (19.46) 
13.47 (8.11) 
18.43 (15.23) 
 
 
-15.96 
-11.00 
 
24 
19 
16 
 
29.38 (17.06) 
15.89 (12.03) 
11.69 (9.49) 
 
 
-13.49 
-17.69 
 
.00 
.42 
.03 
 
.99 
.52 
.87 
Satisfaction with 
Life 
     Baseline 
     Post-treatment 
     3-month 
 
 
21 
19 
15 
 
 
3.13 (1.53) 
3.69 (1.65) 
3.12 (1.44) 
 
 
 
0.56 
-0.01 
 
 
24 
20 
16 
 
 
3.08 (1.40) 
4.15 (1.45) 
4.34 (1.50) 
 
 
 
1.07 
1.26 
 
 
.02 
2.43 
3.48 
 
 
.90 
.13 
.07 
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Chapter 4 
Discussion 
This study sought to extend the literature on the effects of emotion-focused 
treatments for chronic pain by examining a four session group treatment that utilizes 
emotionally oriented techniques to treat pain. This study had three goals. First, it tested 
the hypothesis that this treatment would be effective by examining the pattern, 
magnitude, and reliability of change from baseline to post-treatment and 3-month follow-
up on pain, pain-related disability, pain acceptance, emotional functioning (depression 
and general emotional distress), and satisfaction with life. Second, the study examined 
the ability of baseline measures of depression, stress, emotion regulation ability, and 
treatment attitudes to predict outcome of the treatment. Finally, this study included a 
novel emotional assessment that examined the participants’ ability to communicate 
thoughts and feelings. It was hypothesized that participants who received this emotional 
assessment would report more improvement on the outcome measures than the 
participants who did not receive this assessment. 
Estimating Changes in Outcome 
 To determine the effects of the intervention on the outcome measures of pain, 
pain-related disability, pain acceptance, emotional functioning, and satisfaction with life, 
several sets of analyses were conducted. These analyses, in general, indicated that this 
intervention led not only the statistically significant but clinically meaningful 
improvements in the outcome measures. First, paired-samples t-tests demonstrated 
that the mean scores of the outcome variables were statistically improved from the 
baseline values at both post-treatment and the 3-month follow-up assessment. Thus, 
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this intervention “works” in the sense that there was improvement, on average, among 
the patients.   
More important than demonstrating that the effects are reliably different than 
zero, is estimating the magnitude of the effect of the intervention.  Across measures, the 
sample’s improvement across time ranged from 0.39 to 1.42 standard deviations from 
baseline to post-treatment and a 3-month follow-up. These effects range from small-
moderate to very large. This large variation in effect size may be due in part to the 
variability of domains of functioning assessed. Overall, the most improvements were 
found in the domain of pain, pain-related disability, and chronic pain acceptance, with 
improvements ranging from 0.62 to 1.42 standard deviations from baseline to post-
treatment and the 3-month follow-up. Both the pain and the disability subscales of the 
Brief Pain Inventory demonstrated over 1 standard deviation improvement from baseline 
to post-treatment and the 3-month follow-up assessment.  
Interestingly, the sensory and affective dimensions of pain did not demonstrate 
as large of an improvement (.62 - .78 SDs). Even though both of these measures 
assess perception of pain, they actually assess different elements of pain. The BPI 
requires participants to rate their pain on a 0-10 scale with 10 indicating the greatest 
level of pain whereas the MPQ requires participants to rate how much various sensory 
and affective adjectives describe their pain. Overall pain intensity decreased as 
demonstrated by decreased ratings on the 0-10 scale. Yet, participants still reported 
experiencing pain at the post-treatment and 3-month follow-up, thus, they still rated 
some of the pain adjectives as descriptive of their pain, importantly, with less intensity.  
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Finally, in regard to the pain domain, large effects were demonstrated in pain-
related functioning. First, participants reported over 1 SD improvement at both post-
treatment and the 3-month follow-up on pain-related disability. Participants reported 
substantial improvement for interference from pain in the areas of general activity, 
mood, mobility, and normal work levels at follow-up than at baseline. Additionally, 
participants reported large improvements at both follow-up assessments in their level of 
pain acceptance, which includes an acceptance of experiencing chronic pain along with 
a willingness to engage in activities regardless of pain experience.  
 These large improvements in pain and pain-related functioning are even more 
impressive when considering the brief nature of this treatment. One would not expect 
such significant benefits following only four sessions of a group format. Even though this 
is an uncontrolled study, this level of pain improvement would not be expected to 
happen on its own, with simply the passage of time.  Moreover, comparing the effects of 
this intervention to the benefits noted for pain in other psychological treatments of pain 
reinforces the effectiveness of this treatment. Many studies do not find such substantial 
improvement in pain. Keefe, Caldwell, Williams, and Gill (1990) reported a median 
effect size of 0.50 of cognitive-behavioral treatments, but many of the studies examining 
CBT show even smaller effects with significantly less improvement noted at later follow-
ups as compared to post-treatment effects. Studies of written emotional disclosure show 
modest benefits at best for pain with many of these studies demonstrating small effects 
for pain and other medical conditions (Broderick et al. 2005; Frisina et al. 2004; Gillis et 
al. 2006 Meads et al. 2003). Lumley and colleagues (2008) evaluated an emotional 
exposure based treatment for patients with fibromyalgia and found small to moderate 
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effects on the sensory and affective domains of pain at post-treatment and a 3-month 
follow-up. Thus, the moderate to large and large effect sizes found for pain in this 
emotion focused treatment at both post-treatment and at a 3-month follow-up are 
extremely note worthy. 
Moderate to large improvements were also found for measures of emotional 
functioning. With the exception of the 3-month effect for general emotional distress (d = 
.47), improvement for measures of depression, general distress, and unresolved stress 
symptoms ranged from approximately 0.75 standard deviation to just over 1 standard 
deviation from baseline to post-treatment and a 3 month follow-up. Even though these 
effects are not quite as large as the improvements in pain, they are still substantial 
improvements. Particularly noteworthy are the large effects found in depression and the 
somewhat smaller effects in unresolved stress symptoms, even three months following 
this short-term group treatment. These results are partially expected because these are 
the symptoms targeted by this intervention. A key part of the treatment involves 
expressing emotions and processing unresolved stressful experiences through writing. 
Additionally, it uses mindfulness techniques to guide acceptance of emotions and 
thoughts as normal and not harmful and reengaging in previously avoided activity 
scheduling to help patients re-engage with life. These techniques serve to counter the 
avoidance of stressful thoughts and emotions that are hypothesized to relate to chronic 
pain.  
It is important to note that even though the effect size for depression remained large 
at the 3-month follow-up and was nearly a medium effect for general emotional distress 
at 3 months, these measures had the largest reduction in improvement between post-
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treatment and the 3-month follow-up. It is not surprising that some of the substantial 
treatment gains noted immediately after this brief treatment would be reduced 
somewhat after several months. With the exception of chronic pain acceptance and 
unresolved stress symptoms, which increased slightly in effect size, slight decreases 
are found across the measures. However, regarding depression and general emotional 
distress, it may be that some patients had diagnosable depressive and/or anxiety 
disorders that would not be expected to remit after 4 sessions of group treatment. 
Surprisingly, the least improvement was found for satisfaction with life, which was a 
small to moderate effect at both post-treatment and 3 months. Given the substantial 
improvements in pain and pain-related disability along with depression and stress 
symptoms, one would expect greater improvements life satisfaction than what the 
participants reported at the follow-up assessments. It may be that even though the 
participants demonstrated improved depression, they still are experiencing a significant 
level of depression. An examination of the average depression scores shows that, in 
general, this sample was very depressed at baseline. Thus, even after substantial 
improvement (baseline mean = 27.69; post-treatment mean = 15.00; 3-month follow-up 
mean = 18.31), participants are still reporting levels of depression just under the cut-off 
for this measure at post-treatment and just over the cut-off at the 3-month follow-up. 
Additionally, many of these participants have been dealing with chronic pain for years 
and may have more of a negative outlook on life. They may still fear that the 
improvements in the pain-related domains are temporary and have not yet made many 
changes in their lives.  Furthermore, similarly to the remaining symptoms of depression, 
pain improved substantially but not completely (baseline mean = 5.49; post-treatment 
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mean = 3.18; 3-month mean = 3.03). Some of the participants may only think that a 
complete cessation of pain is successful. As long as they are still experiencing pain, life 
is not as satisfying as it could be. In addition, quality of life is not just thought of as the 
inverse of negative states such as depression or pain. With the consideration of life 
satisfaction as partially independent from the other outcomes, it may be that the patients 
are experiencing reduced symptoms but still are not reporting the addition of many 
positive elements in their lives. Life satisfaction may require positive developments in 
sense of self, relationships, and meeting life’s goals. 
Finally, in addition to estimating change across the sample, this study examined the 
number of individual patients who show a clinically meaningful positive change after 
completing the treatment. A similar pattern of change was found when looking at 
individual change as with the range found on the group effect sizes. The percentage of 
individual patients demonstrating a reliably large effect ranged from 13% to 66%. The 
highest prevalence of clinically significant responders was found on pain and pain-
related disability rated on a 0-10 scale. Nearly 2/3 of the sample had a large effect (less 
than 5% probability that the change is due to chance) at post-treatment for both of these 
outcomes. At the 3-month follow-up, 60% of the sample still had a large effect on this 
measure of pain, and half of the sample still had a large effect for pain-related disability. 
When using a less stringent cut-off to identify a moderate effect, the level of individual 
change was even more impressive. Over 80% of the sample had at least a moderate 
effect for pain at both follow-ups and approximately 80% had at least a moderate effect 
on pain-related disability. These high percentages suggest that the clinically meaningful 
improvements in pain and pain-related disability occurred for the majority of the sample 
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which is much higher than the 1/3 of patients Turk (2005) found improved on average 
with cognitive-behavioral treatments for pain. Chronic pain acceptance was a similarly 
robust change across both time points. Almost half of the sample had a large effect at 
the 3-month follow-up. Including the moderate effect, ¾ of the sample demonstrated 
clinically meaningful improvements in pain acceptance. Lower rates of improvement 
were found on the sensory and affective dimensions of pain, which is consistent with the 
lower effect size noted for the group overall, and again suggests that this manner of 
measuring pain differs from the 0 to 10 rating scale of pain intensity.  
Regarding the measures of emotional functioning, with the exception of the 
unresolved stress symptoms, more individuals showed improvements at the post-
treatment than at the 3-month follow-up (depression and general emotional distress). 
This reduction in the number of responders at the further follow-up assessment provides 
further support for the possibility discussed above that a subset of the patients were 
clinically depressed or anxious and may have experienced a short-term significant 
benefit from these symptoms. Yet, it is also possible that since 3 months has passed 
since the patients’ last assessment, that some of them have experienced stressful 
events and become more depressed or anxious.  Over half of the participants had a 
large effect for unresolved stress symptoms and nearly ¾ of the sample demonstrated a 
moderate effect at both time points. As discussed previously, this improvement is 
partially expected given the treatment’s emphasis on processing stressful experiences. 
As with the previous analyses, the lowest prevalence of clinically significant 
responders was found for satisfaction with life. Approximately half of the sample 
demonstrated at least a moderate effect, but half of the sample did not demonstrate 
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moderate improvement on this outcome. Thus, with the exception of life satisfaction, the 
impressive prevalence of individual change on the primary outcomes of pain, 
depression, and unresolved stress symptoms provides even more support for the 
effectiveness of this treatment. 
Predicting changes in outcome 
The second goal of the study was to identify variables at baseline that predict 
how patients will respond to the treatment. All of the hypothesized predictor variables 
demonstrated some predictive ability. In general, participants with greater levels of 
depression, stress, and discomfort with emotions at baseline improved the most. 
However, there are several caveats. Many of the predictions were significant only at 
post-treatment and not at the 3-month assessment, several of the baseline measures 
predicted change in only a few outcomes, and some of the outcomes, such as 
improvements in pain, were not predicted by any of the baseline measures.  
 First, depression demonstrated strong predictive validity at the post-treatment 
assessment. Participants who reported greater depression at baseline reported greater 
improvements in pain-related disability, the sensory and affective dimensions of pain, 
depression, general emotional functioning, unresolved stress symptoms, and 
satisfaction with life at post-treatment. At 3 months, baseline depression significantly 
predicted only improvement in depression and marginally predicted improvement in 
pain-related disability. These results are consistent with one study that found high levels 
of negative affect at baseline to predict better outcomes of written emotional disclosure 
(Norman et al., 2004). There are a couple of possibilities regarding the loss of predictive 
power at 3 months. First, after examining the partial correlations, a couple of the 
63 
 
 
 
correlations between depression and the outcome measures may have been significant 
with a large sample size (pain, general emotional distress). However, this is not true for 
all of the correlations. Thus, another possibility is that because the overall effects of the 
treatment are lower at the 3-month follow-up, there is less change to predict than at 
post-treatment. Alternatively, it may be important to consider other factors that may 
influence long-term benefits of this treatment. The patients may have made changes in 
their lives that account for the improvements noted at 3 months more so than baseline 
levels of depression before the treatment.  
Second, stress predicted change in outcome for several domains of functioning. 
For the most part, greater stress at baseline predicted improvement in the affective 
dimension of pain, chronic pain acceptance, and unresolved stress symptoms. Only the 
prediction for unresolved stress symptoms was maintained at 3 months. It makes sense 
that participants with more stressful experiences to process benefitted from the writing 
and meditation exercises. Surprisingly, greater distress associated with stressful life 
events at baseline actually predicted less improvement in pain-related disability at post-
treatment. It is unclear why this prediction is in the opposite direction as the others with 
stress and depression. An examination of the correlations between stress and the 
outcome measures suggests that, in general, a larger sample size would likely provide 
enough power to maintain these predictions. 
Third, an examination of the emotion regulation measures revealed variable and 
sometimes conflicting predictive ability of changes in outcome. Alexithymia as a total 
score predicted change only in unresolved stress symptoms. Greater alexithymia at 
baseline predicted improvement in unresolved stress symptoms at post-treatment and 
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marginally predicted improvement at 3 months.  However, the subscales of difficulty 
identifying feelings and the difficulty describing feelings had variable results. Whereas 
greater levels of difficulty describing feelings at baseline predicted improvement in the 
affective dimension of pain at post-treatment, it predicted less improvement in 
satisfaction with life at 3 months. Also in contrast to the improvement in affective pain, 
greater levels of difficulty identifying feelings at baseline predicted less improvement in 
pain on a 0-10 scale at 3 months. It is unclear why the describing feelings and the 
identifying feelings components of alexithymia would predict a different direction in 
similar outcomes. Furthermore, it is interesting that participants reporting more difficulty 
identifying and describing emotions would have greater improvement in unresolved 
stress symptoms, yet still have less improvement in pain and satisfaction with life.  
These mixed results are consistent with much of the literature on alexithymia as it 
relates to health and psychological outcomes with several studies concluding that 
alexithymia predicts poorer outcome (Kelley et al., 1997; Posemato, 2008), yet other 
studies showing more benefits for alexithymic individuals (Baikie, 2008; Solano et al., 
2003).  
Regarding levels of emotional awareness, greater awareness at baseline 
marginally predicted improvement in unresolved stress symptoms at 3 months and in 
satisfaction with life at both time points. However, greater perceived ability to express 
assertive and vulnerable thoughts and feelings at baseline predicted less improvement 
in the sensory dimension of pain and unresolved stress symptoms at post-treatment. 
Thus, it is somewhat confusing that a greater awareness of emotions and being 
alexithymic at the same time led to a greater reduction in unresolved stress symptoms, 
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but a greater perceived ability to communicate emotions led to less reduction in stress 
symptoms.  
Ambivalence over emotional expression yielded the most consistent predictive 
ability with greater baseline levels predicting improvements in pain acceptance at post-
treatment, and improvements in the sensory and affective dimensions of pain, general 
emotional distress, and unresolved stress symptoms at both time points. These findings 
are consistent with another study that found that greater levels of ambivalence at 
baseline predicted improved outcomes following the emotion focused treatment of 
emotional disclosure (Norman et al., 2004). Overall, with respect to the emotion 
regulation predictors, it makes sense that difficulty identifying feelings or less awareness 
of emotional experience would interfere with the beneficial outcomes of this treatment. 
This is consistent with other research that examined lack of emotional awareness as a 
predictor of worse treatment outcome (Kelley et al., 1997; Lumley, Tojek, & Maclem, 
2002). Participants may not be able to fully engage in the processing of emotions 
related to their stressful experiences. However, for those participants who generally 
have an awareness of their emotions but are ambivalent about expressing them or have 
difficulty expressing them, this treatment likely facilitated that process through writing 
exercises in a safe environment. 
Finally, attitudes toward treatment at baseline did not demonstrate much 
predictive utility. In fact, greater positive feelings toward the treatment only marginally 
predicted improvement in chronic pain acceptance. The lack of findings for this predictor 
was surprising given that treatment expectancy and credibility are thought to be strong 
predictors of treatment outcome. The average rating for this scale was 2.68 on a 0-4 
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scale, suggesting that patients had positive expectations overall regarding the 
treatment, yet there was some variability on this measure. Thus, it is also possible that 
patients’ ideas about the treatment when they do not fully understand the treatment lack 
validity for predicting outcome. 
Depression and ambivalence over expressing emotions demonstrated the most 
predictive utility regarding who benefits most from this treatment. Even with these 
measures, most of the predictions were significant at post-treatment, with only marginal 
or no significance at 3 months. As discussed above, it is possible that the reduced 
sample size at the 3-month follow-up compared with the post-treatment assessment 
could account for these differences. There may not have been enough power to 
maintain the predictive ability at 3 months.  The magnitude of some of the correlations 
suggests that the prediction may be maintained with a larger sample size. However, it is 
also possible that different factors account for the improvement at 3 months.  
Evaluating effects of emotional assessment on outcome 
 The third hypothesis that the patients participating in the emotion communication 
exercise would report better outcomes at follow-up than those that did not complete the 
assessment was not supported. There are several possible explanations for the lack of 
group differences on outcomes. There may not be enough power to detect group      
differences with the small sample size in each group.  The emotion assessment was 
brief and may not have been powerful enough to lead to better outcomes. The actual 
exercise only took approximately 10 minutes to complete. Furthermore, participants 
were not given feedback on their performance but rather were invited to explore how 
their performance in the exercise related to their life, stressors, relationships, and pain. 
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This exploration may not have been direct enough for the participants to make the 
connection between their experiences during the exercise and their past stressful 
experiences, emotions, and their current symptoms during the treatment sessions. Even 
though challenges in communicating the thoughts and feelings may have been 
uncovered during the exercise, participants may not have addressed these challenges 
during the treatment. It is also possible that this emotion exercise might be useful as an 
assessment tool but may not be as useful for treatment. Finn’s (1996; 2003) work on 
therapeutic assessment, which this emotional assessment was partially based on, 
involves a more extensive exploration and feedback process. In contrast, the exercise in 
this study was only 10-15 minutes in length, and the exploration part was only several of 
those minutes. It may be relevant to help patients increase their awareness and 
expression of these emotions in preparation for treatment but with a more structured 
feedback process. 
 A surprising finding was that the participants who completed the emotion 
assessment actually reported marginally significantly worse outcomes on satisfaction 
with life at both time points. However, the reliability of these findings is unclear. There 
were no significant differences for the other measures. It does not make sense that the 
participants in this group would report similar symptoms at post-treatment and then 
worse outcomes three months later. Rather, this is likely explained by the smaller 
sample size at 3 months than at post-treatment. Analyses were completed before the 
full sample completed their 3-month follow-up. With their data included, it is likely that 
these differences will be nonsignificant. 
Limitations 
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Many of the limitations of this study have been referenced above in relationship 
to the applicable hypotheses including lack of control group and small sample size. The 
initial goal of this study was to estimate the treatment’s effectiveness. T-tests and effect 
sizes revealed that participants reported several large and moderate effects on most of 
the domains of functioning after completing the treatment. However, because this was 
an uncontrolled study, one cannot conclude that the treatment caused these 
improvements. Thus, it is possible that other factors were responsible for the 
improvements in functioning. The passage of time, attention of a caring professional, 
and expectations/beliefs that they should feel better could account for improvements in 
outcome. Furthermore, since all of the outcomes are self-report measures, there are 
demand effects on the outcomes. However, as discussed above, it is unlikely that these 
factors alone would contribute to this level of improvement given the nature of chronic 
pain, which rarely alleviates on its own in such a short period of time and has not 
typically found to improve this much in previous studies of chronic pain treatment. The 
lack of control group presented another limitation with regard to identifying who benefits 
the most from treatment. Without a control group, this study used correlational analyses 
to predict improvement following the treatment. With the inclusion of a control group one 
can use a moderation analysis to examine interactions between the groups. This type of 
analysis can help elucidate more fully how the predictor relates to outcome by showing 
how a predictor like ambivalence over emotional expression predicts different outcomes 
in a treatment vs. a control group. For example, greater ambivalence may predict better 
outcomes in the treatment group but predict poorer outcomes in the control group.  The 
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current design, however, cannot distinguish whether a measure predicts responses to 
this treatment, or just changes in outcomes in general.  
Also discussed previously, the small sample size was a limitation for the last two 
hypotheses in this study. Regarding the second hypothesis which examined the 
predictive ability of the baseline measures, a reduced sample size at the 3-month 
follow-up may have contributed to the lack of predictive ability at that time point. With a 
larger sample at 3 months, it is possible that some of the significant predictors of 
change in outcome at post-treatment would be maintained at 3 months. Furthermore, as 
discussed above, the small sample size may have limited the ability to find differences 
between the group who completed the emotion assessment exercise and the group who 
did not.  The reason for the small sample size presents another limitation. Recruitment 
began in the fall of 2008 and continued through spring of 2010.Unfortunately, referrals 
for the treatment program reduced significantly and, thus, recruitment was slower than 
expected and after this spring was stopped with a smaller sample than expected. 
Because Dr. Schubiner is the only current provider for this treatment, it was not possible 
to collect participants from other clinics. Another factor that contributed to the smaller 
sample size was missing data. Some of the measures were missing on several 
participants or were not able to be scored because of incomplete responding. 
Therefore, some of the analyses included less participants than were actually included 
in the study.  
Selection bias is another important consideration for this treatment and could 
potentially limit the results. It is a select group of patients who are referred for this 
treatment program in the first place, usually those whose providers are most frustrated 
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with treating them. However, this factor could also provide further support for the 
effectiveness of this study if the treatment is this beneficial for the most complicated 
patients. Another important aspect of selection bias is particularly relevant for this 
treatment. Starting with the initial evaluation, Dr. Schubiner informs the patient about 
mind body syndrome and how it is necessary to refute medical explanations for pain 
and to accept emotional explanations. Some patients may be resistant to this theory, 
and therefore, not complete the treatment. Moreover, it is a subset of those patients 
who will agree to participate in a research study. In this study, 37% of the patients 
referred for the study did not participate. Some of these patients did not participate 
because of logistical reasons including becoming illegible after not participating in the 
treatment and not being able to schedule them for the assessment before the treatment 
started. However, approximately half of this percentage expressed a lack of interest, 
and these patients are likely different in important ways from those patients who are 
interested in research. It is possible that they may not have been as invested in the 
treatment and may not have benefitted as much. 
A final limitation regarding the progression of the treatment program is that the 
treatment actually begins with the initial evaluation with Dr. Schubiner when he explains 
his model for chronic pain and encourages patients to read about mind body syndrome. 
In an attempt to account for this process, key outcome measures were mailed to the 
patients prior to their evaluation; however, most of the baseline measures were 
completed after the patients met with Dr. Schubiner. 
Additionally, although this sample included an adequate number of male patients, 
it was a primarily Caucasian sample which limits generalizability of the findings.  Also, 
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another limitation could be the reliance on self-report measures in this study. Self-report 
measures are useful but the study could have been strengthened with the inclusion of 
an objective measure of pain tolerance or the observations of another person.  
Future Research 
 Other than the ideas discussed previously, including the utilization of a 
randomized controlled design, a larger, more diverse sample, and the incorporation of 
objective measures of improvement, future studies should continue to explore potential 
moderators of predictors of treatment outcome. This study found support for using 
depression and ambivalence over emotional expression as predictors of change in 
outcome, but many of the other predictors had scattered and sometimes inconsistent 
results. Re-examining these predictors in a larger, more diverse sample will help 
determine their utility as predictors. Also, this study did not assess beliefs about pain or 
specific measures of pain coping as typically measured in cognitive-behavioral 
treatment studies. It would be interesting to compare the predictive ability of these 
measures with the emotion regulation measures used in this study. It would also be 
valuable to directly compare this intervention with a cognitive-behavioral intervention to 
see if this treatment does cause greater improvement in symptoms than CBT. 
Additionally, this study attempted to determine who benefits from this treatment 
but future studies should address how this treatment might work. This treatment 
consists of six components: reading about mind body syndrome, repudiating physical 
explanations for symptoms, writing exercises, reflecting with meditative exercises, 
reprogramming the mind, and rebuilding the life. Over four weeks, patients are 
instructed to complete daily exercises of writing, meditation, and behavioral activation. 
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This study demonstrated that patients reported improved outcome after completing 
these exercises. However, it is unknown how these components lead to change. One 
possibility is that patients are processing avoided emotions and unresolved stressors, 
and that changes in these domains are responsible for improvements in pain, disability, 
and emotional functioning. Yet another possibility is that patients are increasing their 
self-efficacy to make changes and cope with their pain or that they are changing the 
way that they think about their pain. Future studies should evaluate these variables over 
the course of treatment to see how they relate to changes in outcome. Similarly, 
dismantling studies would be beneficial to evaluate which of these components are 
most influential on outcome. It is likely that each of these components is not equally 
effective. Moreover, some patients may be responsive to different components. 
 Further exploration of using the novel emotion assessment as preparation for 
treatment is also warranted. It will be important to address the limitations described 
above including a sample size with sufficient power to detect group differences. This 
exercise could also be a useful predictor of treatment outcome and would provide an 
objective assessment of emotional expressive ability. Given the conflicting results found 
with the self-report emotion regulation predictors in this sample, it would be interesting 
to see how an objective measure of ability related to change in outcomes. Another goal 
for future research will be to evaluate this treatment program when facilitated by 
providers other than Dr. Schubiner. It is possible that, because he created the program 
and strongly advocates it, part of the beneficial outcomes is due to his charisma and 
belief. He has also published a comprehensive, self-explanatory treatment workbook 
that patients can complete on their own. Future studies could evaluate the effectiveness 
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of completing this treatment without the guidance and interaction with a facilitator. 
Alternatively, research has shown than when participants benefit more from written 
emotional disclosure when they know their writings will be read by someone (Radcliffe 
et al., 2007). Thus, including a sharing component in the group where people disclose 
their stressful experiences and related emotions could prove beneficial. 
 In conclusion, this study suggests that Schubiner’s treatment is very effective for 
patients with chronic pain. In fact, this brief, group treatment led to substantial 
improvements in pain and pain-related disability as well as improvements in emotional 
functioning. Furthermore, this study contributed to the growing movement that seeks to 
identify differential response to treatment for chronic pain. Patients with significant 
depression who were aware of their emotions but uncertain about expressing them 
benefitted most from this treatment. These results provide further support for the theory 
that stressful experiences, poor emotion regulation skills, and emotional disorders relate 
to chronic pain and that, more importantly, addressing these elements in an emotion-
focused treatment program results in improvements in unresolved stress, emotional 
functioning, and in chronic pain. 
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APPENDIX A (Informed Consent) 
 
 
St. John Health/Providence Hospital and Medical Centers 
CONSENT TO PARTICIPATE IN A RESEARCH STUDY 
AND 
AUTHORIZATION TO USE OR DISCLOSE PROTECTED HEALTH INFORMATION 
FOR RESEARCH 
 
TO BE CONDUCTED 
AT 
PROVIDENCE HOSPITAL AND MEDICAL CENTERS 
 
 
Title:  Evaluating a Chronic Pain Treatment Program 
 
Principal Investigators:  Howard Schubiner, M.D., Providence Hospital  
Office Phone:  (248) 849-4728 
Mark A. Lumley, Ph.D.   Wayne State University 
Office Phone:  (313) 577-2773 
 
Sub-Investigators and/or Study Staff: Amanda Burger, M.A., Wayne State University 
Maren Hyde, Wayne State University 
      Alaa Hijazi, Wayne State University 
 
Background and Purpose 
 
This form contains information about a research study.  You understand that you are being asked 
to participate in a research study sponsored by Providence Hospital and Wayne State University.  
If you choose to participate in this research study, you should clearly understand all information 
contained in this consent before you agree to participate by signing your name to the last page.  
After you sign the form, you will be given a copy, and an additional copy will remain in your 
medical chart. 
 
You understand that this is a research study.  You have been asked to participate because you are 
a patient with a chronic pain problem and you plan to participate in a treatment program offered 
by Dr. Howard Schubiner at Providence Hospital and Medical Center.  All subjects participating 
in research must volunteer, and be informed about the purpose, risks, benefits if any, and 
alternatives.  If you have any questions about this research or the document, please ask. 
 
The purpose of this study is to a) evaluate how well Dr. Schubiner’s treatment program works 
for people with chronic pain problems, determine which patients are most likely to benefit, and 
test the effects of a communication exercise. 
 
Study Description, Location,  and Duration    
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If you choose to take part in this study you will be asked to come to the hospital two times to 
complete some questionnaires and be interviewed about your pain, functioning, stress, and 
relationships.  These two visits will occur before and soon after you participate in Dr. 
Schubiner’s treatment program.  The first session at the hospital will take approximately 2 hours.  
In addition to completing various questionnaires, half of the patients will be asked to participate 
in a communications exercise and discussion, which will take about 15 minutes.  If you are 
randomly assigned to this exercise (like by the flip of a coin), then you will be asked to 
demonstrate how you might communicate different feelings to someone, such as being assertive, 
or telling someone that you care.  At the end of this exercise, you will be asked to answer several 
interview questions about your communication style, emotions, and pain.  This communications 
exercise will be audiotaped.  There is a 50-50 chance that you will be asked to do this 
communications exercise.  
After the first session, you will then participate in the treatment program just as you would have 
if you were not participating in this study. Within a few weeks of completing the treatment 
program, you will return to the hospital to complete questionnaires about your health, pain, and 
mood, and you will be interviewed about your reactions to the treatment program.  This session 
will take approximately 1 hour. 
 
Finally, in order to evaluate the outcomes of the treatment over time, we will mail you follow-up 
questionnaires 3 months and 6 months after the program ends, and ask you to report again on 
your pain, health, and stress by returning the questionnaires in a stamped envelope that we 
provide.  These questionnaires should take about 20 minutes each. 
Approximately 100 people will be in this study. Your total participation will be about 4 hours 
over a time span of seven to eight months. Your part in the study will be completed once you 
have returned the final packet of questionnaires six months after you have completed the 
treatment program. 
 
Possible Risks and Discomforts  
 
We expect the risks of your participating in this study to be minimal and unlikely.  However, you 
may experience a negative mood when questionnaires and/or interviews ask to you think about 
experiences that may have been difficult for you. You may consult Dr. Schubiner or ask the 
research team for a referral if you experience such discomfort.  There may be other risks that are 
unknown at this time.  
 
Benefits 
There may be no direct benefit to you in participating in the study.  It is possible that you may 
learn new things about yourself and experience improvements in your health, pain, and mood. In 
the future, other patients may benefit from the results of this study, when they become known.   
 
Alternative Treatments 
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An alternative is to not participate.  You do not have to participate in this research study in order 
to receive Dr. Schubiner’s treatment program for your chronic pain.   
 
Voluntary Participation 
You understand that your participation in this study is voluntary and that your refusal to 
participate will cause no penalty or loss of benefits that you would otherwise receive.  If you 
decide to participate, you may change your mind about being in the study, and may quit at any 
time without penalty or loss of benefits regarding your future care.  If new information becomes 
available during the study that may affect your willingness to continue in the study, your doctor 
and/or his/her associate will discuss this information with you.  Also, your doctor may stop your 
participation at any time if he/she feels that is in your best interest. 
 
Compensation 
 
You will receive a total of $100 for completing all four assessments. You will receive $50 for 
completing the first 2-hour assessment at the hospital, $30 for completing the 1-hour assessment 
at the hospital, and $10 each for completing each of the mailed questionnaire packets three and 
six months later. Because the treatment program is not part of the research study you will not 
receive any compensation for completing treatment, and you or your insurer will need to pay for 
the treatment. 
No funds have been set aside for injured research subjects.  While medical care is available 
should an injury occur, the cost will be billed to you or your insurer in the ordinary manner. 
 
Confidentiality Of Records 
The principal investigators will have access to your medical records and your test results.  While 
absolute confidentiality cannot be guaranteed, you understand that all medical records and 
research material that could identify you will be kept as confidential as possible within state and 
federal laws.  However, you risk the loss of confidentiality if you are thought to be at risk for 
self-harm or harming another, if there is a concern that child abuse or elder abuse has possibly 
occurred, or if it is discovered that you have a reportable communicable disease (certain sexually 
transmitted diseases and/or HIV), then this information must be released to the appropriate 
authorities or public health department. If you disclose illegal criminal activities, illegal 
substance abuse, or violence, this information may be released to the appropriate authorities.  
You also understand that your medical records could be examined by the sponsor, the 
Institutional Review Board (a group of medical and lay people at this hospital charged with 
protecting human subjects’ rights) or government agencies in order to verify the data collected 
during this research study.  If the results of this study are presented in any public forum, you will 
not be identified by name. 
 
Questions Regarding this Study 
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If you have any questions about your rights as a subject in this clinical research study, you may 
contact the IRB (Institutional Review Board) office at 248 849-8889 at Providence Hospital and 
Medical Center. 
If you have any questions regarding a research-related injury, you can contact: Dr. Howard 
Schubiner at (248) 849-4728. 
 
Authorization to Use and Disclose Protected Health Information (PHI) 
Your participation in this study will require the use and disclosure of certain medical and other 
information about you.  You will not be able to participate if you do not agree to the use and 
disclosure of your information.     
 
The protected health information (PHI) that may be used or disclosed includes: 
•  All information collected during the research study as described in this form,  
•  The information that is contained in any medical record that is created during your 
participation in this research, and 
•  Other information in your medical record that may be considered related to your participation 
in this research, which may include:  your medical history, physical examination results, 
laboratory test results or other test results (like an x-ray, scan, biopsy, EKG). 
 
Who may see, use or disclose your PHI:  
 The researchers and members of the research team    
  Other health care providers or employees of St. John Health who provide services to you for 
this study  
  Representatives of the Institutional Review Board, the FDA (Food and Drug Administration), 
or other governmental agencies involved in research monitoring   
  Members of the safety monitoring board 
  Other agencies as required by law  
 The sponsor, ________________ 
 A clinical research organization, or other agent of the sponsor  
 A laboratory outside of St. John Health System 
 
What This Authorization Means 
You understand that we cannot guarantee that your protected health information shared or 
disclosed under this Authorization could not be additionally shared or disclosed by the individual 
or organization that receives the information, and the privacy of your PHI may no longer be 
protected by the law. 
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You have the right to not agree to disclose your PHI.  However, if you do not agree by signing 
this Authorization, you will not be able to participate in this research study.   
If you do sign below, you have the right to withdraw your permission at any time, but you must 
do so in writing.  You may send the written withdrawal to: 
Dr. Howard Schubiner 
Dept. of Internal Medicine 
Providence Hospital and Medical Centers 
16001 W. Nine Mile Rd. 
Southfield, MI   48075 
You may no longer be allowed to participate in the research if you withdraw your permission.  
Also, you understand that any information collected before written notice of withdrawal is 
received will be shared as you have agreed.   
You have the right to review your PHI.  However, if you agree to participate in the research 
study and sign below, you will not be able to look at your research information until the research 
study is completed.    
You will receive a copy of this document, the Consent to Participate in a Clinical Research Study 
and Authorization to Use or Disclose Protected Health Information for Research.  
Expiration Date 
 
Your authorization (permission) to use and disclose your health information will continue 
indefinitely, subject to the procedures and limits described in this form. Your health information 
will only be used for the purposes defined within this consent and authorization form. 
Other Considerations 
You have fully discussed and understand the purpose of this clinical research study and how it 
will be carried out.  You have been allowed to ask questions about the study and all of your 
questions have been answered.  You have read this consent form or had the complete form read 
to you and understand it. You know that your participation in this study is fully voluntary and 
you may withdraw at any time.  If you refuse to participate or later withdraw from the study, it 
will not affect your care in any way. You also understand that by consenting to participate in this 
study, you are not waiving any other legal rights you may have because you are a subject in this 
study or as a patient at Providence Hospital & Medical Center or at Wayne State University / 
Detroit Medical Center. 
 
Questions Regarding the Study  
 
If you have any questions about your rights as a subject in this clinical research study, you may 
contact the IRB (Institutional Review Board) office at (248) 849-8889 at Providence Hospital 
and Medical Center.  You may contact David Svinarich, Ph.D. of the Providence Hospital 
Research Department at (248) 849-3326 for any questions about your rights as a research 
participant.  You may also contact the Chair of the Wayne State University Human Investigation 
Committee at (313) 577-1628. 
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You have the right to ask questions concerning this study at any time, and you are urged to do 
so. If you have questions concerning the study or have a research related injury, you should 
contact Dr. Howard Schubiner at (248) 849-4728 or Dr. Mark Lumley at (313) 577-2773. 
 
Signatures 
 
Research Subject 
 
I voluntarily agree to participate in this research study.  I understand the information printed on 
this form.  I have discussed this study, its risks and potential benefits, and my other choices with 
____________________.  My questions so far have been answered.  I understand that if I have 
more questions or concerns about the study or my participation as a research subject, I may 
contact one of the people listed above.  I understand that I will receive a copy of this form at the 
time I sign it and later upon request.  I understand that if my ability to consent for myself 
changes, either I or my legal representative may be asked to re-consent prior to my continued 
participation in this study. 
 
Signature of Subject: _______________________________________________ Date: 
___________ 
 
Name (Print legal name): 
_____________________________________________________________ 
 
 
Witness 
I observed the above subject sign this consent document.                         
 
Signature of Witness: ______________________________________________ Date: 
___________ 
 
Name: 
____________________________________________________________________________ 
 
 
Principal Investigator 
I have given this research subject (or his/her legally authorized representative, if applicable) 
information about this study that I believe is accurate and complete.  The subject has indicated 
that he or she understands the nature of the study and the risks and benefits of participating. 
 
Signature of Investigator: ___________________________________________ Date: 
___________ 
 
Name: ___________________________________ Title: 
___________________________________ 
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APPENDIX B (MEASURES) 
 
 
BRIEF PAIN INVENTORY 
1. Please rate your pain by circling the one number that best describes your pain at 
its worst in the last week. 
 0 1 2 3 4 5 6 7 8 9 10 
    No pain              Pain as bad as 
               you can imagine 
2. Please rate your pain by circling the one number that best describes your pain at 
its least in the last week. 
 0 1 2 3 4 5 6 7 8 9 10 
    No pain              Pain as bad as 
               you can imagine 
3. Please rate your pain by circling the one number that best describes your pain on 
the average. 
 0 1 2 3 4 5 6 7 8 9 10 
    No pain              Pain as bad as 
               you can imagine 
4. Please rate your pain by circling the one number that tell how much pain you 
have right now. 
 0 1 2 3 4 5 6 7 8 9 10 
    No pain              Pain as bad as 
               you can imagine 
For the next set of questions, choose the one number that describes how, during the 
past week, pain has interfered with the following activities.  Please use the 0 to 10 
scale  where a 0 means that “pain does not interfere with that activity” and a 10 
means that “pain completely interferes.” 
Does not 
interfere  
Completely 
interferes 
0 1 2 3 4 5 6 7 8 9 10 
 
a) General Activity……………………………………………..…0   1   2   3   4   5   6   7   
8   9   10 
b) Mood……………………………………………………………....0   1   2   3   4   5   6   
7   8   9   10 
c) Mobility (ability to get around)……………….………….0   1   2   3   4   5   6   7   8   9   
10 
d) Normal Work (includes both work outside the home and housework) 
     .……………………………………………………………………….0   1   2   3   4   5   6   
7   8   9   10 
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e) Relations With Other People………………………..……0   1   2   3   4   5   6   7   8   
9   10 
f) Sleep………………………………………………………..………0   1   2   3   4   5   6   
7   8   9   10 
g) Enjoyment Of Life……………………………………..………0   1   2   3   4   5   6   7   
8   9   10 
h) Self Care (taking care of your daily needs)………...0   1   2   3   4   5   6   7   8   9   
10 
i) Recreational Activities……………………………………....0   1   2   3   4   5   6   7   8   
9   10 
j) Social Activities……………………………………………..….0   1   2   3   4   5   6   7   
8   9   10 
k) Communication With Others……………………..………0   1   2   3   4   5   6   7   8   
9   10 
l) Learning New Information or Skills…………………….0   1   2   3   4   5   6   7   8   9   
10 
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CENTER FOR EPIDEMIOLOGIC STUDIES—DEPRESSION SCALE 
Circle the number of each statement which best describes how often you felt or 
behaved this way – DURING THE PAST WEEK. 
 Rarely or 
none of 
the time 
(less than 
1 day) 
Some or a 
little of 
the time 
(1-2 days) 
Occasionally 
or a moderate 
amount of the 
time (3-4 
days) 
Most or 
all of the 
time (5-7 
days) 
During the past week: 0 1 2 3 
1) I was bothered by things 
that usually don’t bother me 
0 1 2 3 
2) I did not feel like eating; 
my appetite was poor 
0 1 2 3 
3) I felt that I could not 
shake off the blues even 
with help from my family 
and friends 
0 1 2 3 
4) I felt that I was just as 
good as other people 
0 1 2 3 
5) I had trouble keeping my 
mind on what I was doing 
0 1 2 3 
6) I felt depressed 0 1 2 3 
7) I felt that everything I did 
was an effort 
0 1 2 3 
8) I felt hopeful about the 
future 
0 1 2 3 
9) I thought my life had 
been a failure 
0 1 2 3 
10) I felt fearful 0 1 2 3 
11) My sleep was restless 0 1 2 3 
12) I was happy 0 1 2 3 
13) I talked less than usual 0 1 2 3 
14) I felt lonely 0 1 2 3 
15) People were unfriendly 0 1 2 3 
16) I enjoyed life 0 1 2 3 
17) I had crying spells 0 1 2 3 
18) I felt sad 0 1 2 3 
19) I felt that people 
disliked me 
0 1 2 3 
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20) I could not get “going” 0 1 2 3 
 
Satisfaction with Life Scale 
Below are five statements that you may agree or disagree with. Using the 1 - 7 scale 
below, indicate your agreement with each item by placing the appropriate number on 
the line preceding that item. Please be open and honest in your responding. 
 
• 7 - Strongly agree  
• 6 - Agree  
• 5 - Slightly agree  
• 4 - Neither agree nor disagree  
• 3 - Slightly disagree  
• 2 - Disagree  
• 1 - Strongly disagree 
____ In most ways my life is close to my ideal.  
____ The conditions of my life are excellent. 
____ I am satisfied with my life. 
____ So far I have gotten the important things I want in life. 
____ If I could live my life over, I would change almost nothing. 
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Chronic Pain Acceptance Questionnaire 
Directions: below you will find a list of statements. Please rate the truth of each 
statement as it applies to you. Use the following rating scale to make your choices. 
For instance, if you believe a statement is `Always True,' you would write a 6 in the 
blank next to that statement 
 
 
1. I am getting on with the business of living no matter what my level of pain is ......... 
2. My life is going well, even though I have chronic pain ......... 
3. It's OK to experience pain ......... 
4. I would gladly sacrifice important things in my life to control this pain better ......... 
5. It's not necessary for me to control my pain in order to handle my life well ......... 
6. Although things have changed, I am living a normal life despite my chronic pain 
......... 
7. I need to concentrate on getting rid of my pain ......... 
8. There are many activities I do when I feel pain ......... 
9. I lead a full life even though I have chronic pain ......... 
10. Controlling pain is less important than any other goals in my life ......... 
11. My thoughts and feelings about pain must change before I can take important 
steps in my life ......... 
12. Despite the pain, I am now sticking to a certain course in my life ......... 
13. Keeping my pain level under control takes first priority whenever I'm doing 
something ......... 
14. Before I can make any serious plans, I have to get some control over my pain 
......... 
15. When my pain increases, I can still take care of my responsibilities ......... 
16. I will have better control over my life if I can control my negative thoughts about 
pain ......... 
17. I avoid putting myself in situations where my pain might increase ......... 
18. My worries and fears about what pain will do to me are true ......... 
19. It's a relief to realize that I don't have to change my pain to get on with my life 
......... 
20. I have to struggle to do things when I have pain ......... 
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IMPACT OF EVENT SCALE-REVISED 
     Instructions: The following is a list of difficulties people sometimes have after stressful life events. Please read 
each item, and then indicate how distressing each difficulty has been for you during the past 7 days with respect 
to _______________, how much were you distressed or bothered by these difficulties? 
   
Not 
at all 
 
A little 
bit 
 
Mode
rate-ly 
 
Quite a 
bit 
 
Ex-
treme-
ly 
1 Any reminder brought back feelings about it. 
 
0 1 2 3 4 
2 I had trouble staying asleep. 
 
0 1 2 3 4 
3 Other things kept making me think about it. 
 
0 1 2 3 4 
4 I felt irritable and angry. 
 
0 1 2 3 4 
5 I avoided letting myself get upset when I thought about it or was 
reminded of it. 
 
0 1 2 3 4 
6 I thought about it when I didn’t mean to. 
 
0 1 2 3 4 
7 I felt as if it hadn’t happened or wasn’t real. 
 
0 1 2 3 4 
8 I stayed away from reminders about it. 
 
0 1 2 3 4 
9 Pictures about it popped into my mind. 
 
0 1 2 3 4 
10 I was jumpy and easily startled. 
 
0 1 2 3 4 
11 I tried not to think about it. 
 
0 1 2 3 4 
12 I was aware that I still had a lot of feelings about it, but I didn’t deal with 
them. 
 
0 1 2 3 4 
13 My feelings about it were kind of numb. 
 
0 1 2 3 4 
14 I found myself acting or feeling like I was back at that time. 
 
0 1 2 3 4 
15 I had trouble falling asleep. 
 
0 1 2 3 4 
16 I had waves of strong feelings about it. 
 
0 1 2 3 4 
17 I tried to remove it from my memory. 
 
0 1 2 3 4 
18 I had trouble concentrating. 
 
0 1 2 3 4 
19 Reminders of it caused me to have physical reactions, such as sweating, 
trouble breathing, nausea, or a pounding heart. 
 
0 1 2 3 4 
20 I had dreams about it. 
 
0 1 2 3 4 
21 I felt watchful and on guard. 
 
0 1 2 3 4 
22 I tried not to talk about it. 0 1 2 3 4 
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TAS-20 
 
Please indicate how much you agree or disagree with each of the following statements 
by writing a number from 1 to 5 in the blank in front of the statement. Use this scale: 
 
1 = Strongly disagree 
2 = Disagree 
3 = Neither disagree nor agree 
4 = Agree 
5 = Strongly agree 
 
1.  I am often confused about what emotion I am feeling. 
2.  It is difficult for me to find the right words for my feelings. 
3.  I have physical sensations that even doctors don’t understand. 
4.  I am able to describe my feelings easily. 
5.  I prefer to analyze problems rather than just describe them. 
6.  When I am upset, I don’t know if I am sad, frightened or angry. 
7.  I am often puzzled by sensations in my body. 
8.  I prefer to just let things happen rather than to understand why they turned out that way. 
9.  I have feelings that I cant quite identify. 
10.  Being in touch with emotions is essential. 
11.  I find it hard to describe how I feel. 
12.  People tell me to describe my feelings more. 
13.  I don’t know what’s going on inside me.  
14.  I often don’t know why I am angry. 
15.  I prefer talking to people about their daily activities rather than their feelings. 
16.  I prefer to watch “light” entertainment shows rather than psychological dramas. 
17.  It is difficult for me to reveal my innermost feelings, even to close friends. 
18.  I can feel close to someone, even in moments of silence. 
19.  I find examination of my feelings useful in solving personal problems. 
20.  Looking for hidden meaning in movies or plays distracts from their enjoyment. 
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Code ___ 
AEQ 
 
Below are some statements that refer to how people sometimes feel and act. Using the 
following scale, rate each statement to indicate how frequently you have felt or 
experience each one.  
 
1  2  3  4  5 
  I have never       I feel like 
  felt like this       this a lot 
 
The statements may consist of 2 thoughts. Carefully read the statement as a whole before deciding on 
how characteristic it is of you. For example, consider item: 
 
“ I try to honestly criticize others for their own good, but I worry they may get angry with me if I do so” 
 
You would give this time a high rating if and only If both parts of the statement apply to you; that is, you 
try to honestly criticize others and you worry about their getting angry. If only one part of the statement 
applies to you, you would give this item a lower rating. It is important to consider the complete thoughts 
being expressed before you respond. 
 
___1.  I make an effort to control my temper at all times even though I’d like to act on these feelings at 
times.  
___ 2.  Often I’d like to show others how I feel, but something seems to hold me back.  
___3.   I try to refrain from getting angry at my family even though I want to at times.  
___ 4.  I try to show people that I love them, although at times I am afraid that it may make me appear 
weak or too sensitive. 
___ 5.  Often I find that I am not able to tell others how much they really mean to me. 
___ 6.   I want to tell someone when I love them, but it is difficult to find the right words. 
___ 7.   I would like to express my disappointment when things don’t go as well as planned, but I don’t 
want to appear vulnerable. 
___ 8.   I would like to be more spontaneous in my emotional reactions, but I just can’t seem to do it 
___ 9.   I try to suppress my anger, but I would like other people to know how I feel.  
___ 10. It is hard to find the right words to indicate to others what I am really feelings. 
___ 11. I worry that if I express negative emotions such as fear and anger, other people will not approve 
of me. 
___ 12. I feel guilty after I have expressed my anger to someone. 
___ 13. I often cannot bring myself to express what I am really feeling. 
___ 14. After I express anger at someone, it bothers me for a long time.  
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Communicating Thoughts and Feelings Questionnaire 
(Mark A. Lumley & Amanda Burger, Wayne State University) 
 
In this questionnaire, you will be presented with a series of situations that could happen 
between you and another person, and a response that you might make to that person.  You 
should read the situation and the response, and then think about how likely you are to make that 
response. 
 
For each scenario, you should think about making the response to each of four different 
people—your father (or the primary male authority during your first 18 years), your mother, your 
significant other, and a stranger (someone with whom you have no relationship).  
 
A significant other is the person with whom you feel closest, typically a spouse or partner. If you 
do not have a spouse or partner, then you should select anyone that you relate to on a regular 
basis. Please indicate who your significant other is (check one): 
 
__Spouse __Partner/Companion __ Friend __ Neighbor 
 
___Housemate/Roommate ___Child or other relative  __Other (describe):________ 
 
 
For each of the four relationships, enter a number from 0 to 4 regarding how likely you are to 
make that response to that person. 
 
0 = Definitely can not do it  
1 = Probably can not do it 
2 = Can probably do it, but with some difficulty 
3 = Can do it with only a little difficulty 
4 = Can do it easily 
 
1. You have done something wrong to the person.  Can you tell that person that you are sorry 
for doing it to them? 
 
____   Father 
____   Mother 
____   Significant other 
____   Stranger 
 
 
2. You are asked to do something for the person, but you do not want to.  Can you tell that 
person that you do not want to do it? 
 
____   Father 
____   Mother 
____   Significant other 
____   Stranger 
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3. The person has helped you.  Can you tell that person that you are thankful for what they have 
done?  
 
____   Father 
____   Mother 
____   Significant other 
____   Stranger 
 
 
4. The person has done something to you that makes you mad.  Can you tell that person that 
you are mad because of what they did? 
 
____   Father 
____   Mother 
____   Significant other 
____   Stranger 
 
 
5. The person has achieved something or has positive qualities.  Can you compliment or praise 
that person? 
 
____   Father 
____   Mother 
____   Significant other 
____   Stranger 
 
 
6. You want the person to do something for you. Can you directly tell that person to do it? 
 
____   Father 
____   Mother 
____   Significant other 
____   Stranger 
 
 
7. Somebody has hurt you in the past and seeks your forgiveness.  Can you tell them that you 
forgive them? 
 
____   Father 
____   Mother 
____   Significant other 
____   Stranger 
 
 
8. You disagree with the person’s opinion about a topic that is important to you, and believe that 
they are wrong.  Can you tell that person that you disagree with them and that they are wrong? 
 
____   Father 
____   Mother 
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____   Significant other 
____   Stranger 
 
 
9. You feel love toward the person.  Can you tell that person “I love you.”? 
 
____   Father 
____   Mother 
____   Significant other 
____   Stranger 
 
 
11. You want to make a connection with the person.  Can you give that person an embrace or 
hug? 
 
____   Father 
____   Mother 
____   Significant other 
____   Stranger 
 
 
 
13. You have done something that you feel guilty or ashamed about.  Can you tell or share with 
the person what you have done? 
 
____   Father 
____   Mother 
____   Significant other 
____   Stranger 
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Date ________________ 
 
Treatment Attitudes Survey:  Pre-Treatment 
 
1. What do you think causes your pain? (Ex. stress, diet, genetics, injury, etc.).  Please describe as 
fully as possible.  
 
________________________________________________________________________________ 
 
________________________________________________________________________________ 
        
2. How much do you think that biological, medical, or genetic factors cause your pain? 
                  
                  0                           1                               2                                  3                                4 
     Not at all               A little bit                Moderately                  Quite a lot                Completely 
 
3. How much do you think that psychological factors such as stress or emotions cause your pain? 
 
                   0                          1                               2                                  3                                4 
     Not at all               A little bit                Moderately                  Quite a lot                Completely 
 
4.   How much do you think that stressful life events or emotional trauma caused your pain problem? 
 
                   0                          1                               2                                  3                                4 
     Not at all               A little bit                Moderately                  Quite a lot                Completely 
 
       5.  How much to you think that stressful life events or emotional trauma make your pain worse? 
 
                   0                          1                               2                                  3                                4 
     Not at all               A little bit                Moderately                  Quite a lot                Completely 
 
6.   How much do you think that the source or cause of your pain is in your mind? 
 
                   0                          1                               2                                  3                                4 
     Not at all               A little bit                Moderately                  Quite a lot                Completely 
 
7. How much do you think that your mind can eliminate the pain? 
 
    0                            1                               2                                  3                                4 
     Not at all               A little bit                Moderately                  Quite a lot                Completely 
 
       8.   How much do you agree with the suggestion that a medical disease is NOT the source of your 
pain?   
    0                            1                               2                                  3                                4 
     Not at all               A little bit                Moderately                  Quite a lot                Completely 
 
9.   How much of Dr. Sarno’s book, The Mindbody Prescription, did you read? 
 
                   0                          1                               2                                  3                                4 
     Not at all               A little bit                Moderately                  Quite a lot                Completely 
 
10.  How much did your pain improve after reading the book? 
 
                   0                          1                               2                                  3                                4 
     Not at all               A little bit                Moderately                  Quite a lot                Completel 
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APPENDIX C (Emotional Assessment) 
 
 
Communicating Feelings Therapeutic Assessment Exercise 
(Assessor Script and Rating Scale) 
(Mark A. Lumley & Amanda Burger, Wayne State University) 
 
 
“People have important thoughts and feelings about things that happen in relationships.  Some 
thoughts and feelings can be expressed easily comfortably, but other feelings are hard to 
express or communicate. 
 
In this exercise, I am going to ask you to demonstrate how you might communicate 7 different 
feelings.  For each one, I’ll describe a situation, and ask you to demonstrate how you might 
communicate it, using both words as well as nonverbal expressions, such as with your tone of 
voice, your eyes, your hands, and your posture.  I’ll give you more explanations as we go along. 
 
(For each task, read the italicized text. Each section has a default phrase for participants who 
struggle with the task. Rate the patient’s performance on each task using the 0-4 rating scale 
below.) 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ used the default phrase 
 
 
1. Declining a request 
 
Imagine that you have been asked to do something for someone, but you do not want to 
it.  How would you express that you do not want to do it? 
 
 
a) Generic demonstration (without any specific target or example) 
 
First, I would like you to demonstrate how you might decline a request in general; that is, without 
thinking of any specific person or example in your life.  I want to see what it is like for you to 
communicate with your words and actions, so I would like you to demonstrate how you might 
decline a request in the most direct, genuine, and straightforward way possible, using your tone 
of voice, emotions, mannerisms, and actions. 
 
 
(If participant struggles have them use the phrase: “No I do not want to do that.”) 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
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___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ used the default phrase 
 
 
b) Specific target and example 
 
Now I would like to repeat this exercise, but this time, have you demonstrate it with respect to 
someone in your life who you need to decline a request from.  Ideally, it should be someone in 
your life right now, about a situation with that person that you would like to decline, but it could 
be a person and situation from your past.  Take a few moments and think about that person and 
the situation, and what you are going to say to them. (Pause).  Now imagine that the person is 
sitting in that chair.  You should tell them directly and honestly your feelings and wishes. You 
should use their first name and be specific about what the request is that you are declining.  You 
should use any words, tone, actions, or mannerisms to help get your message across genuinely 
and directly. 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ not able to think of an example 
 
 
2.  Expressing gratitude 
 
Imagine that somebody has done something helpful to you. How would you express your 
thankfulness or gratitude to that person for what they have done? 
 
a) Do it generically (without any specific target or example) 
 
First, I would like you to demonstrate how you might express to someone that you are thankful 
for something they have done, but without thinking of any specific person or example in your 
life.  I want to see what it is like for you to communicate with your words and actions.  Please do 
so in a direct, genuine, and straightforward way using your tone of voice, emotions, 
mannerisms, and actions. 
 
 
(If participant struggles have them use the phrase: “Thank you for helping me.”) 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ used the default phrase 
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b) Do it specifically to a difficult target and with specific example 
 
Now take a few minutes to think about someone in your life who you need to express that you 
are thankful to them because of something they have done for you.  Ideally, it should be 
someone in the present to whom it is difficult to express thanks to.  Take a couple of minutes 
and think about that person and situation, and how you are going to express it to them. Now 
imagine that the person is sitting in that chair.  You should tell them directly, honestly your 
feelings and wishes. You should use their first name and be specific about what you are 
thankful for.  You should use any actions or mannerisms that help get your message across 
genuinely and directly. 
 
(If the participant cannot think of their own example have them identify a person with whom it 
would be difficult to communicate anger and use the phrase “Thank you for helping me.” and 
still imagine they are speaking to that person.) 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ used the default phrase 
 
 
 
3. Making a demand 
 
Imagine that you need help and believe that somebody should help you. How would you 
express to that person that you expect them to help you? 
 
a) Do it generically (without any specific target or example) 
 
First, I would like you to demonstrate making a demand of someone without thinking of any 
specific person or example in your life.  I want to see what it is like for you to express this with 
your words and actions.  Please do so in a direct, genuine, and straightforward way using your 
tone of voice, emotions, mannerisms, and actions. 
 
 
(If participant struggles have them use the phrase: “I need you to help me.”) 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ used the default phrase 
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b) Do it specifically to a difficult target and with specific example 
 
Now take a few minutes to think about someone in your life who you think you should help you 
do something.  Ideally, it should be someone in the present who it is difficult to make a demand 
to.  Take a couple of minutes and think about that person and situation, and what you are going 
to say to them. Now imagine that the person is sitting in that chair.  You should tell them directly, 
honestly your feelings and wishes. You should use their first name and be specific about what 
help you need.  You should use any actions or mannerisms that help get your message across 
genuinely and directly. 
 
(If the participant cannot think of their own example have them identify a person with whom it 
would be difficult to make a demand and use the phrase “I need you to help me.” and still 
imagine they are speaking to that person.) 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ used the default phrase 
 
 
4. Expressing love 
 
Imagine that you are close to a person and love them.  How would you express to that 
person that you love them? 
 
a) Do it generically (without any specific target or example) 
 
First, I would like you to demonstrate telling somebody that you love them without thinking of 
any specific person or example in your life.  I want to see what it is like for you to communicate 
this with your words and actions.  Please do so in a direct, genuine, and straightforward way 
using your tone of voice, emotions, mannerisms, and actions. 
 
 
(If participant struggles have them use the phrase: “I love you.”) 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ used the default phrase 
 
 
b) Do it specifically to a difficult target and with specific example 
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Now take a few minutes to think about someone in your life who you need to express to them 
that you love them.  Ideally, it should be someone in the present who it is difficult to express 
love to.  Take a couple of minutes and think about that person and situation, and what you are 
going to say to them. Now imagine that the person is sitting in that chair.  You should tell them 
directly, honestly your feelings and wishes. You should use their first name and be specific 
about what help you need.  You should use any actions or mannerisms that help get your 
message across genuinely and directly. 
 
(If the participant cannot think of their own example have them identify a person with whom it 
would be difficult to communicate love and use the phrase “I love you.” and still imagine they are 
speaking to that person.) 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ used the default phrase 
 
 
 
5.  Disagreeing and stating that a person is wrong about an important topic 
 
Imagine that you disagree with someone and believe that they are wrong about some topic.  
How would you tell that person that you think they are wrong? 
 
a) Do it generically (without any specific target or example) 
 
First, I would like you to demonstrate expressing to somebody that you disagree with them and 
that they are wrong about an important topic, but do this without thinking of any specific person 
or example in your life.  I want to see what it is like for you to communicate that with your words 
and actions.  Please do so in a direct, genuine, and straightforward way using your tone of 
voice, emotions, mannerisms, and actions. 
 
 
(If participant struggles have them use the phrase: “I think that you are wrong and I disagree 
with you.”) 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ used the default phrase 
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b) Do it specifically to a difficult target and with specific example 
 
Now take a few minutes to think about someone in your life who you need to express that you 
disagree with them, and that they are wrong.  Ideally, it should be someone in the present who it 
is difficult to disagree with.  Take a couple of minutes and think about that person and situation, 
and what you are going to say to them. Now imagine that the person is sitting in that chair.  You 
should tell them directly, honestly your feelings and wishes. You should use their name and be 
specific about what you disagree about and how wrong they are. You should use any actions or 
mannerisms that help get your message across genuinely and directly. 
 
(If the participant cannot think of their own example have them identify a person with whom it 
would be difficult to communicate anger and use the phrase “I think that you are wrong and I 
disagree with you” and still imagine they are speaking to that person.) 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ used the default phrase 
 
 
6. Apologizing 
 
Imagine that you have done something wrong to another person. How would you 
express to that person that you are sorry for doing it to them? 
 
a) Do it generically (without any specific target or example) 
 
First, I would like you to demonstrate expressing to somebody that you are sorry for something 
you have done, without thinking of any specific person or example in your life.  I want to see 
what it is like for you to communicate with your words and actions the following idea.  Please do 
so in a direct, genuine, and straightforward way using your tone of voice, emotions, 
mannerisms, and actions. 
 
  
(If participant struggles have them use the phrase: “I am sorry that I hurt your feelings.”) 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ used the default phrase 
 
 
 
b) Do it specifically to a difficult target and with specific example 
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Now take a few minutes to think about someone in your life to whom you need to express that 
you are sorry for something you have done.  Ideally, it should be someone in the present who it 
is difficult to apologize to.  Take a couple of minutes and think about that person and situation, 
and what you are going to say to them. Now imagine that the person is sitting in that chair.  You 
should tell them directly, honestly your feelings and wishes. You should use their first name and 
be specific about what you are sorry for.  You should use any actions or mannerisms that help 
get your message across genuinely and directly. 
 
(If the participant cannot think of their own example have them identify a person with whom it 
would be difficult to apologize to and use the phrase “I am sorry that I hurt your feelings.” and 
still imagine they are speaking to that person.) 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ used the default phrase 
 
 
 
7.  Communicating anger 
 
Imagine that somebody has made you mad. How would you tell that person that you are 
angry with them? 
 
a) Do it generically (without any specific target or example) 
 
First, I would like you to demonstrate how you would express that you are mad because of 
something they have done, without thinking of any specific person or example in your life.  I 
want to see what it is like for you to communicate with your words and actions the following 
idea.  Please do so in a direct, genuine, and straightforward way using your tone of voice, 
emotions, mannerisms, and actions. 
 
  
(If participant struggles have them use the phrase: “I am angry with you.”) 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ used the default phrase 
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b) Do it specifically to a difficult target and with specific example 
 
Now take a few minutes to think about someone in your life to whom you need to express that 
you are angry with them because of something they have done.  Ideally, it should be someone 
in the present who it is difficult to show anger to.  Take a couple of minutes and think about that 
person and situation, and what you are going to say to them. Now imagine that the person is 
sitting in that chair.  You should tell them directly, honestly your feelings and wishes. You should 
use their first name and be specific about what made you mad.  You should use any actions or 
mannerisms that help get your message across genuinely and directly. 
 
(If the participant cannot think of their own example have them identify a person with whom it 
would be difficult to communicate anger and use the phrase “I am angry with you.” and still 
imagine they are speaking to that person.) 
 
___ 0 = Did not do it at all 
___ 1 = Did it with great difficulty 
___ 2 = Did it with some difficulty 
___ 3 = Did it with a little difficulty 
___ 4 = Did it easily 
 
___ used the default phrase 
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APPENDIX D (Exploration Questions) 
 
 
Exploration Questions 
 
1. Were there any parts of these tasks that were particularly difficult for you? 
 
2. Were there any parts of these tasks that were particularly easy for you? 
 
3. How typical were these responses to your everyday communication with people 
in your life? 
 
4. How does the way you handle your emotions and needs affect your pain and 
your relationships? 
 
5. Is there anything you would like to change about how you express your emotions 
and needs? 
 
6. What kind of treatment goals can you make based on what you have learned 
today? 
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Chronic pain is a leading cause of suffering, disability, and high health care 
costs. Traditional treatment approaches such as medical or cognitive-behavioral 
interventions have produced variable and often limited results. Research has suggested 
that increased rates of stressful life events, emotional disorders, and emotion regulation 
deficits contribute to the development and maintenance of chronic pain problems that 
lack clear, peripheral, biological causes. This study examined the effectiveness of an 
innovative, emotion-focused treatment that directly targets patients’ unresolved stress 
and emotional avoidance and sought to identify predictors of treatment outcome. 
Additionally, this study explored the effects of a novel, emotional assessment on 
treatment outcome by randomizing half of the participants to complete this assessment 
prior to treatment.  
To be included in the study, patients reported chronic pain for at least 3 months 
duration that had substantial psychological factors that contributed to the pain. Forty-six 
patients participated (76% women and 91% Caucasian). Pain, pain-related disability, 
depression, general emotional distress, and satisfaction with life were assessed at 
120 
 
 
 
baseline, post-treatment, and a 3-month follow-up. Stressful life events and emotion 
regulation ability were also assessed at baseline. The 4-session group treatment uses 
readings, writing about emotions, meditation, and other techniques to help people 
identify, understand, and verbalize emotions related to stressful life events or emotional 
conflict.  
Results indicated significant improvements for pain, pain-related disability and 
acceptance, depression, general emotional distress, and satisfaction with life. Effect 
sizes were generally medium or large and reliable change analyses indicated that 
approximately half of the patients showed at least a moderate effect across all the 
outcome domains. Increased levels of baseline depression and stress generally 
predicted improved treatment outcomes, whereas poorer baseline emotion regulation 
predicted inconsistent results. The baseline emotional assessment had no significant 
effect on the outcome measures. This study suggests that this emotion-focused 
treatment led to substantial improvements in pain, pain-related functioning, and 
emotional symptoms. Further research should seek to clarify the predictors of treatment 
outcome and the process by which it works. 
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